<SEC-DOCUMENT>0001437749-19-019919.txt : 20191010
<SEC-HEADER>0001437749-19-019919.hdr.sgml : 20191010
<ACCEPTANCE-DATETIME>20191010165450
ACCESSION NUMBER:		0001437749-19-019919
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20191010
DATE AS OF CHANGE:		20191010

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Diffusion Pharmaceuticals Inc.
		CENTRAL INDEX KEY:			0001053691
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				300645032
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-233686
		FILM NUMBER:		191146551

	BUSINESS ADDRESS:	
		STREET 1:		2020 AVON COURT
		STREET 2:		SUITE 4
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902
		BUSINESS PHONE:		(434) 220-0718

	MAIL ADDRESS:	
		STREET 1:		2020 AVON COURT
		STREET 2:		SUITE 4
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RestorGenex Corp
		DATE OF NAME CHANGE:	20140307

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stratus Media Group, Inc
		DATE OF NAME CHANGE:	20080722

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FERIS INTERNATIONAL, INC.
		DATE OF NAME CHANGE:	20080228
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>dffn20191009_424b3.htm
<DESCRIPTION>FORM 424B3
<TEXT>
<html><head>
	<title>dffn20190906_s1.htm</title>

	<!-- Generated by ThunderDome Portal - 10/10/2019 6:37:44 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%; vertical-align: top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"><b>PROSPECTUS</b></p>
			</td>
			<td style="width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 3pt; text-align: right;">Filed Pursuant to</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 3pt; text-align: right;">Rule 424(b)(3)</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 3pt; text-align: right;">Registration No. 333-233686</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 3pt; text-align: right;">&nbsp;</p>

<div style="text-align: center;">
<div><img alt="" src="d01.jpg"></div>
</div>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>1,382,913</b><b> </b><b>Shares of Common Stock</b><b> </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Issuable upon Exercise of Outstanding Warrants</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">This prospectus relates to the resale, from time to time, by the selling stockholders identified in this prospectus under the caption &#8220;Selling Stockholders,&#8221; of up to 1,382,913 shares of our common stock, par value $0.001 per share, issuable upon exercise of certain outstanding common stock purchase warrants. We are not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale of shares of common stock by the selling stockholders. We will receive proceeds from cash exercise of the warrants which, if exercised in cash with respect to all of the 1,382,913 shares of common stock, would result in gross proceeds of approximately $7.0 million to us. The selling stockholders will bear all commissions and discounts, if any, attributable to the sale of the shares.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The selling stockholders may sell the shares of our common stock offered by this prospectus from time to time on terms to be determined at the time of sale through ordinary brokerage transactions or through any other means described in this prospectus under the caption &#8220;Plan of Distribution.&#8221; The shares of common stock may be sold at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market price or at negotiated prices.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Our common stock is listed on The NASDAQ Capital Market under the symbol &#8220;DFFN.&#8221; On October 9, 2019, the last reported sale price of our common stock was $1.80.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Investing in our common stock involves a high degree of risk. Before making an investment decision, please read &#8220;Risk Factors&#8221; on page 11 of this prospectus.</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">The date of this prospectus is October 10, 2019.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>TABLE OF CONTENTS</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align:bottom;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:bottom;width:8.1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: right;"><b>Page</b></p>
			</td>
			<td style="vertical-align:bottom;width:8.1%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">About this Prospectus</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">ii</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Forward-Looking Statements</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:2%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 4.6%; text-align: right;">iii</td>
			<td style="vertical-align:bottom;width:1.5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Prospectus Summary</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align: bottom; width: 4.6%; text-align: right;">1</td>
			<td style="vertical-align:bottom;width:1.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Offering</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:2%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">5</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Risk Factors</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">6</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Security Ownership of Beneficial Owner and Management</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:2%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">7</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Use of Proceeds</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">9</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Description of Capital Stock</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:2%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">10</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Selling Stockholders</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">14</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Plan of Distribution</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">15</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Legal Matters</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">17</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Experts</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">17</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Where You Can Find Additional Information</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">17</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:90.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Incorporation of Certain Information by Reference</p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:4.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">18</p>
			</td>
			<td style="vertical-align:bottom;width:1.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">i</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>ABOUT THIS PROSPECTUS</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">This prospectus relates to the resale by the selling stockholders identified in this prospectus under the caption &#8220;Selling Stockholders,&#8221; from time to time, of up to 1,382,913 shares of our common stock, par value $0.001 per share, issuable upon exercise of certain outstanding common stock purchase warrants. We are not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale of shares of common stock by the selling stockholders.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (SEC). It omits some of the information contained in the registration statement and reference is made to the registration statement for further information with regard to us and the securities being offered by the selling stockholders. Any statement contained in the prospectus concerning the provisions of any document filed as an exhibit to the registration statement or otherwise filed with the SEC is not necessarily complete, and in each instance, reference is made to the copy of the document filed.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">You should read this prospectus, any documents that we incorporate by reference in this prospectus and the additional information described below under &#8220;Where You Can Find Additional Information&#8221; and &#8220;Incorporation of Certain Information By Reference&#8221; before making an investment decision. You should rely only on the information contained or incorporated by reference in this prospectus. We have not authorized any other person to provide you with different information. If anyone provides you with additional, different or inconsistent information, you should not rely on it. We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in this prospectus were made solely for the benefit of the parties to such agreement, including in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">You should not assume that the information in this prospectus or any documents we incorporate by reference herein is accurate as of any date other than the date on the front of those documents. Our business, financial condition, results of operations and prospects may have changed since those dates.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Unless the context indicates otherwise, as used in this prospectus, the terms &#8220;Diffusion,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Diffusion Pharmaceuticals Inc., a Delaware corporation, We have registered trademarks for&nbsp;Diffusion and RestorGenex. All other trade names, trademarks and service marks appearing in this prospectus are the property of their respective owners. Use or display by us of other parties&#8217; trademarks, trade dress or products is not intended to and does not imply a relationship with, or endorsements or sponsorship of, us by the trademark or trade dress owner.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We have registered trademarks for&nbsp;Diffusion and RestorGenex. All other trade names, trademarks and service marks appearing in this prospectus are the property of their respective owners. Use or display by us of other parties&#8217; trademarks, trade dress or products is not intended to and does not imply a relationship with, or endorsements or sponsorship of, us by the trademark or trade dress owner.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">ii</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>FORWARD-</b><b>LOOKING STATEMENTS</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">This prospectus, any accompanying prospectus supplement and the other information and documents incorporated by reference herein include forward-looking statements. We may, in some cases, use terms such as &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;anticipates,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;approximately&#8221; or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Forward-looking statements appear in and are incorporated by reference into a number of places throughout this prospectus supplement and any accompanying prospectus supplement and include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, our ongoing and planned preclinical development and clinical trials, the timing of and our ability to make regulatory filings and obtain and maintain regulatory approvals for our product candidates, our intellectual property position, the degree of clinical utility of our products, particularly in specific patient populations, expectations regarding clinical trial data, our ability to commercialize our product candidates, our results of operations, cash needs, financial condition, liquidity, prospects, growth and strategies, the industry in which we operate and the trends that may affect the industry or us.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on the economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. Although we believe that we have a reasonable basis for each forward-looking statement contained in or incorporated by reference into this prospectus and any accompanying prospectus supplement, we caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate may differ materially from the forward-looking statements contained in and incorporated by reference into this prospectus any accompanying prospectus supplement. In addition, even if our results of operations, financial condition and liquidity, and the development of the industry in which we operate are consistent with the forward-looking statements contained in and incorporated by reference into this prospectus any accompanying prospectus supplement, they may not be predictive of results or developments in future periods.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">Actual results could differ materially from our forward-looking statements due to a number of factors, including risks related to:</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">our ability to obtain additional financing;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">our estimates regarding expenses, capital requirements and needs for additional financing;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">the success and timing of our preclinical studies and clinical trials;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; line-height: 1;">the difficulties in obtaining and maintaining regulatory approval of our products and product candidates, and the labeling under any approval we may obtain;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">our plans and ability to develop and commercialize our product candidates;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">our failure to recruit or retain key scientific or management personnel or to retain our executive officers;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">the accuracy of our estimates of the size and characteristics of the potential markets for our product candidates and our ability to serve those markets;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">regulatory developments in the United States and foreign countries;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">the rate and degree of market acceptance of any of our product candidates;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">obtaining and maintaining intellectual property protection for our product candidates and our proprietary technology;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">our ability to operate our business without infringing the intellectual property rights of others;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">recently enacted and future legislation regarding the healthcare system;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">iii</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">our ability to satisfy the continued listing requirements of the Nasdaq Capital Market or any other exchange that our securities may trade on in the future;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">our ability to continue as a going concern;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">the success of competing products that are or may become available; and</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; line-height: 1;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">&#8226;</p>
			</td>
			<td>
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">the performance of third parties, including contract research organizations and manufacturers.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 27pt; text-align: justify;">You should also read carefully the factors described in the &#8220;Risk Factors&#8221; section contained in this prospectus and incorporated by reference herein from our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 to better understand the risks and uncertainties inherent in our business and underlying any forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements contained in or incorporated by reference into this prospectus will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">Any forward-looking statements that we make in or incorporate by reference into this prospectus speak only as of the date of such statement, and, except as required by applicable law, we undertake no obligation to update such statements to reflect events or circumstances after the date of this prospectus or to reflect the occurrence of unanticipated events. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.75pt;margin-top:0pt;text-align:left;">For all forward-looking statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:0.75pt;margin-top:0pt;text-align:left;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">iv</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;text-transform:uppercase;"><b>PROSPECTUS SUMMARY</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><i>The following summary highlights information contained elsewhere or incorporated by reference in this prospectus. This summary does not contain all of the information you should consider before investing in the securities. Before making an investment decision, you should read the entire prospectus carefully, including the matters discussed under the heading &#8220;Risk Factors&#8221; in this prospectus.</i></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i>&nbsp;</i></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Diffusion Pharmaceuticals Inc.</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Business O</b><b>verview</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">We are a clinical stage biotechnology company developing new treatments for life threatening conditions by improving the body&#8217;s ability to bring oxygen to the areas where it is needed most. We are developing our lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (&#8220;TSC&#8221;), for use in those life threatening conditions in which cellular oxygen deprivation (&#8220;hypoxia&#8221;) is the basis for significant unmet medical needs. TSC is designed to safely and selectively target and re-oxygenate the micro-environment of hypoxic cells, and can potentially be used in many indications, including stroke, oncology and cardiovascular disease. In stroke, TSC helps promote the diffusion of oxygen into those brain cells in which oxygen-deprivation causes neuronal death resulting in patient mortality or morbidity. In cancer, TSC re-oxygenates treatment-resistant cancerous tissue, making the cancer cells up to three times more susceptible to the therapeutic effects of standard-of-care radiation therapy and chemotherapy.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">A range of tissue types, including both normal and cancerous cells, has been shown to be safely re-oxygenated in our preclinical and clinical studies using TSC&#8217;s novel mechanism of action. We believe TSC&#8217;s ability to re-oxygenate normal tissue that has become oxygen-deprived provides opportunities for new therapeutic approaches to conditions ranging from stroke and emergency medicine to cardiovascular and neurodegenerative diseases. In oncology, we believe TSC&#8217;s therapeutic potential is not limited to one specific tumor type, thereby making it potentially useful to improve standard-of-care treatments in many life-threatening cancers. Given TSC's safety profile and animal data, we could, with appropriate funding, move directly into Phase 2 studies for TSC in many such cancers. The successful completion of trials for TSC or any other potential product candidate in these or any other indication is dependent upon our ability to further raise necessary capital.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">We believe that TSC has potential applications in stroke and emergency medicine. A Phase 2 trial in cooperation with UCLA and the University of Virginia to test TSC in the treatment of acute stroke has received approval for enrollment by the FDA, with the first enrolled patient expected in Q3 2019. This trial, which will feature in-ambulance dosing of TSC, is named the PreHospital Acute Stroke Therapy - TSC (PHAST - TSC) and is expected to enroll 160 patients, with 80 in the treatment arm and 80 in the control arm. We believe in-ambulance dosing of TSC could significantly cut the time in which the stroke-related oxygen deprivation to brain cells goes untreated, potentially leading to a better outcome for stroke victims treated in this manner. In the last quarter of 2018, we received FDA permission to begin patient enrollment in the PHAST - TSC Phase 2 trial and expect to begin enrollment in the third quarter 2019. Subject to receipt of adequate funding to support the PHAST &#8211; TSC trial, we expect to data readout during the first half of 2021.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">Our primary oncology program targets TSC against treatment-resistant brain cancer. A Phase 2 clinical program, completed in the second quarter of 2015, evaluated 59 patients with newly diagnosed glioblastoma multiforme (&#8220;GBM&#8221;), a particularly deadly form of primary brain cancer. GBM affects approximately 12,000 patients annually in the United States and approximately 35,000 patients annually worldwide. This open label, historically controlled study demonstrated a favorable safety and efficacy profile for TSC when combined with GBM&#8217;s standard of care, including a 37% improvement in overall survival over the control group at two years. A particularly strong efficacy signal was seen in the inoperable patients, where survival of TSC-treated patients at two years was increased by almost four-fold over the controls. In December 2017, the Company initiated the INvestigation of TSC Against Cancerous Tumors (INTACT) Phase 3 trial in the newly diagnosed inoperable GBM patient population. The trial is designed to enroll 236 patients in total, with 118 in the treatment arm and 118 in the control arm.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">The trial is beginning with an open label 8 patient safety run-in for which enrollment has completed and is now closed. With the FDA&#8217;s permission, a total of 19 patients were enrolled to ensure 8 complete data sets. The INTACT Trial Data Safety Monitoring Board (DSMB) met in the third quarter 2019 and recommended that the study be continued. The board concluded that no adverse safety signal had been observed, and unanimously recommended continuing the study as planned using the highest tested dose of TSC &#8211; 1.5 mg/kg &#8211; during the adjuvant treatment chemotherapy period with temozolomide. Commencement of enrollment in the randomization portion of the INTACT Phase 3 Trial is contingent upon our entering into a strategic partnership providing the necessary resources to undertake the full trial.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">In addition to the TSC programs, we are exploring alternatives regarding how best to capitalize upon our product candidate RES-529, which may include possible out-licensing and other options. RES-529 is a novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase 1 clinical trials for age-related macular degeneration and was in preclinical development in oncology. RES-529 has shown activity in both in vitro and in vivo glioblastoma animal models and has been demonstrated to be orally bioavailable and capable of crossing the blood-brain barrier.&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Summary of Current Product Candidate Pipeline</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">The following table, as of June 30, 2019, summarizes the targeted primary indications for Diffusion&#8217;s lead molecule, TSC, and RES-529:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><img alt="" src="a01.jpg"></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>TSC Stroke Program</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">We believe that TSC has a potential application as a treatment for stroke. Approximately 800,000 strokes occur in the United States each year, with an estimated annual cost of $43.0 billion. The damage from a stroke begins immediately upon onset: brain cell death begins at the beginning of a stroke. A stroke can take a significant toll on its victims. Among long-term stroke survivors, approximately 66% of stroke patients end up needing mental or physical rehabilitation, approximately 40% are classified as moderately to severely disabled after the initial few days of recovery, and approximately 10% of stroke patients require long-term care.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">We believe in-ambulance dosing of TSC could significantly cut the time in which the stroke-related oxygen deprivation to brain cells goes untreated, potentially leading to a better outcome for stroke victims treated in this manner. Half of all stroke patients are transported to hospitals by emergency medical services (EMS), such as ambulances, with estimates of up to 80% of all patients in urban and suburban areas being transported by EMS.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">2</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">TSC has shown pre-clinical efficacy as a potential treatment for ischemic and hemorrhagic stroke in laboratory testing. Rabbits receiving TSC alone at one hour after developing a clot have shown a statistically significant positive response to treatment. Additionally, rabbits receiving TSC in conjunction with Tissue Plasminogen Activator (tPA) at three hours after developing a clot have shown a statistically significant positive response to treatment. Additionally, rats dosed with TSC in a hemorrhagic stroke showed a statistically significant decrease in damaged brain cells. The following charts provide additional detail on these animal studies:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<div style="text-align: center;"><img alt="" src="a02.jpg"></div>

<div style="text-align: center;"><img alt="" src="a03.jpg"></div>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:18pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">3</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Corporate Information</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">We are a Delaware corporation that was incorporated in June 2015. Prior to June 2015, we were a Nevada corporation. We maintain our principal executive offices at 1317 Carlton Avenue, Suite 200, Charlottesville, VA 22902. Our telephone number there is (434) 220-0718. The address of our website is&nbsp;<i>www.diffusionpharma.com</i>. The information set forth on, or connected to, our website is expressly not incorporated by reference into, and does not constitute a part of, this prospectus.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">We are a &#8220;smaller reporting company&#8221; as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and have elected to take advantage of certain of the scaled disclosure available for smaller reporting companies in this prospectus as well as our filings under the Exchange Act.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:27pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Description of the Private Placement</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">In May 2019, we entered into a Securities Purchase Agreement (the &#8220;<u>Purchase Agreement</u>&#8221;) with certain institutional and accredited investors providing for the sale in a registered direct offering by the Company of 1,317,060 shares of our common stock. Concurrently with the closing of the transactions contemplated by the Purchase Agreement, we issued to the investors warrants to purchase an aggregate of 1,317,060 shares of our common stock at an initial exercise price equal to $5.00 per share (the &#8220;<u>Investor Warrants</u>&#8221;) and to the placement agent warrants to purchase up to 65,853 shares of common stock at an initial exercise price equal to $6.11875 per share (the &#8220;<u>PA Warrants</u>&#8221;, and together with the Investor Warrants, the &#8220;<u>Warrants</u>&#8221;). The Investor Warrants are exercisable for approximately five and one-half years beginning on the date of their issuance. The PA Warrants have a term of approximately five years from the date of issuance and (other than the exercise price noted above) are otherwise substantially similar to the Investor Warrants. H.C. Wainwright &amp; Co., LLC acted as the placement agent.</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">The Warrants are exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and by payment in full in immediately available funds for the number of shares of common stock purchased upon such exercise. No fractional shares of common stock will be issued in connection with the exercise of a warrant. In lieu of fractional shares, we will either pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up to the next whole share.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">A holder will not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would beneficially own in excess of 4.99% (or, at the election of the holder, 9.99%) of the number of shares of our stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the warrants. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% upon notice to us, provided that any increase in such percentage shall not be effective until 61 days after such notice to us.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">In the event of a fundamental transaction, as described in the Warrants and generally including any reorganization, recapitalization or reclassification of our common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the holders of the Warrants will be entitled to receive upon exercise of the Warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the Warrants immediately prior to such fundamental transaction. In addition, upon a fundamental transaction, the holder shall have the right to receive a payment in cash, or under certain circumstances in other consideration, from us at the Black Scholes value as described in the Warrants.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">4</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 0.75pt;text-align:center;"><b>THE </b><b>OFFERING</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 0.75pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 279pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Shares of common stock</b><b> offered&nbsp;by the s</b><b>elling </b><b>s</b><b>tockholders</b><b>:</b></p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">1,382,913 shares of common stock issuable upon exercise of the Warrants.</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 279pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Shares of common stock outstanding after </b><b>completion of this offering</b><b>,</b><b> </b><b>assuming full exercise </b><b>the Warrants </b><b>for cash</b><b>:</b></td>
			<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">6,076,203</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:279pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Terms of the </b><b>Offering</b><b>:</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">The selling stockholders, including their transferees, donees, pledgees, assignees and successors-in-interest, may sell, transfer or otherwise dispose of any or all of the shares of common stock offered by this prospectus from time to time on The NASDAQ Capital Market or any other stock exchange, market or trading facility on which the shares are traded or in private transactions. The shares of common stock may be sold at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market price or at negotiated prices.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:279pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Use of Proceeds: </b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">All proceeds from the sale of shares of common stock issuable upon exercise of the Warrants will be for the account of the selling stockholders. We will not receive any proceeds from the sale of common stock offered pursuant to this prospectus. However, we will receive proceeds upon any cash exercise of the Warrants. See the section titled &#8220;Use of Proceeds&#8221; in this prospectus.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:279pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>NASDAQ Capital Market symbol:</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">DFFN</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:279pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Trading:</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">Our shares of common stock currently trade on The NASDAQ Capital Market. There is no established trading market for the common stock purchase warrants and we do not intend to list the common stock purchase warrants on any exchange or other trading system.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:279pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><b>Risk Factors:</b></p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">Investing in our securities involves a high degree of risk and purchasers of our securities may lose their entire investment. See &#8220;Risk Factors&#8221; below and the other information included elsewhere in this prospectus for a discussion of factors you should carefully consider before deciding to invest in our securities.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The number of shares of our common stock to be outstanding after this offering is based on 4,693,290 shares of common stock outstanding as of June 30, 2019 and excludes as of that date:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="width:22pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin: 0pt 0pt 0pt 18pt; text-align: justify; font-size: 10pt; text-indent: -18pt;">309,276 shares of common stock issuable upon the exercise of outstanding stock options under the Diffusion Pharmaceuticals Inc. 2015 Equity Incentive Plan, as amended (the &#8220;2015 Equity Plan&#8221;), at a weighted-average exercise price of $55.78 per share;</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="width:22pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin: 0pt 0pt 0pt 18pt; text-align: justify; font-size: 10pt; text-indent: -18pt;">3,469,925 shares of common stock issuable upon the exercise of outstanding warrants, at a weighted-average exercise price of $15.11 per share; and</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="width:22pt;vertical-align:top;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#8226;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin: 0pt 0pt 0pt 18pt; text-align: justify; font-size: 10pt; text-indent: -18pt;">19,740 shares of common stock reserved for future issuance under the 2015 Equity Plan.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">All share information contained in this prospectus reflects the completion on December 13, 2018, of a 1-to-15 reverse stock split (the &#8220;<u>Reverse Stock Split</u>&#8221;) of our common stock. No fractional shares were issued in connection with the Reverse Stock Split. Stockholders who otherwise would have been entitled to receive fractional shares of common stock had their holdings rounded up to the next whole share. Proportional adjustments were made to the Company&#8217;s outstanding warrants, stock options and other equity securities and to the 2015 Equity Incentive Plan, as amended, to reflect the Reverse Stock Split, in each case, in accordance with the terms thereof.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">5</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>RISK FACTORS</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Investing in our securities involves a high degree of risk. Prior to making a decision about investing in our securities, you should consider carefully all of the information included and incorporated by reference or deemed to be incorporated by reference in this prospectus or the applicable prospectus supplement, including the risk factors incorporated by reference herein from our Annual Report on Form 10-K for the year ended December 31, 2018, as updated by annual, quarterly and other reports and documents we file with the SEC after the date of this prospectus and that are incorporated by reference herein, or in the applicable prospectus supplement. Each of these risk factors could have a material and adverse effect on our business, results of operations, financial position or cash flows, which may result in the loss of all or part of your investment. Please also read carefully the section above entitled &#8220;Forward-Looking Statements.&#8221;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b><i>An investment in our securities is speculative and there can be no assurance of any return on any such investment.</i></b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">An investment in our securities is speculative and there is no assurance that investors will obtain any return on their investment. Investors will be subject to substantial risks involved in an investment in the Company, including the risk of losing their entire investment.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b><i>There may be future sales of our securities or other dilution of our equity, which may adversely affect the market price of our common stock.</i></b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We are generally not restricted from issuing additional common stock, including any securities that are convertible into or exchangeable for, or that represent the right to receive, common stock. The market price of our common stock could decline as a result of sales of common stock or securities that are convertible into or exchangeable for, or that represent the right to receive, common stock after this offering or the perception that such sales could occur.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b><i>If we cannot continue to satisfy the Nasdaq&nbsp;Capital Market continued listing standards and other Nasdaq rules, our common stock could be delisted, which would harm our business, the trading price of our&nbsp;common stock, our ability to raise additional capital and the liquidity of the market for our&nbsp;common stock.</i></b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Our common stock is currently listed on the Nasdaq Capital Market. To maintain the listing of our common stock on the Nasdaq Capital Market, we are required to meet certain listing requirements, including, among others, either: (i) a minimum closing bid price of $1.00 per share, a market value of publicly held shares (excluding shares held by our executive officers, directors and 10% or more stockholders) of at least $1 million and stockholders&#8217; equity of at least $2.5 million; or (ii) a minimum closing bid price of $1.00 per share, a market value of publicly held shares (excluding shares held by our executive officers, directors and 10% or more stockholders) of at least $1 million and a total market value of listed securities of at least $35 million.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">There is no assurance that we will continue to meet the minimum closing price requirement and other listing requirements.&nbsp;In the event that our common stock is delisted from Nasdaq and is not eligible for quotation or listing on another market or exchange, trading of our common stock&nbsp;and warrants could be conducted only in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it could become more difficult to dispose of, or obtain accurate price quotations for, our common stock and warrants, and there would likely also be a reduction in our coverage by securities analysts and the news media, which could cause the price of our common stock to decline further.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><i><b>The Bylaws of the Company include a forum selection clause, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents.</b></i></p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Our Bylaws (the &#8220;<u>Bylaws</u>&#8221;) require that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim for breach of a fiduciary duty owed by any of our directors, officers, employees or agents to us or our stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our Certificate of Incorporation or our Bylaws or (iv) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein.</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">This exclusive forum provision will not apply to claims under the Exchange Act, but will apply to other state and federal law claims including actions arising under the Securities Act (although our stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder).&nbsp; Section 22 of the Securities Act, however, creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.&nbsp; Accordingly, there is uncertainty as to whether a court would enforce such a forum selection provision as written in connection with claims arising under the Securities Act. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock is deemed to have notice of and consented to the foregoing provisions. This forum selection provision in our Bylaws may limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents, which may discourage lawsuits against us and such persons. It is also possible that, notwithstanding the forum selection clause included in our Bylaws, a court could rule that such a provision is inapplicable or unenforceable.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">6</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SECURITY OWNERSHIP OF BENEFICIAL OWNERS AND MANAGEMENT </b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt; background-color: rgba(0, 0, 0, 0); color: rgb(0, 0, 0);">The following table sets forth certain information with respect to the beneficial ownership of our common stock as of June 30, 2019, for:</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt; background-color: rgba(0, 0, 0, 0); color: rgb(0, 0, 0);">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(1)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">each person or group of affiliated persons known by us to be the beneficial owner of more than 5% of our common stock;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(2)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">each of our named executive officers;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(3)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">each of our directors; and</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(4)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">all current executive officers and directors as a group.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Applicable percentage ownership is based on 4,693,290 shares of common stock outstanding as of June 30, 2019. We have determined beneficial ownership in accordance with SEC rules. The information does not necessarily indicate beneficial ownership for any other purpose. Under these rules, the number of shares of common stock deemed outstanding includes shares issuable upon exercise of options or warrants, or the conversion of convertible notes, held by the respective person or group that may be exercised or converted within 60 days after June 30, 2019. For purposes of calculating each person&#8217;s or group&#8217;s percentage ownership, stock options and warrants exercisable, and notes convertible, within 60 days after June 30, 2019 are included for that person or group, but not the stock options of any other person or group.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Unless otherwise indicated and subject to applicable community property laws, to our knowledge, each stockholder named in the following table possesses sole voting and investment power over the shares listed. The address for each beneficial owner, unless otherwise noted, is c/o Diffusion Pharmaceuticals Inc. 1317 Carlton Avenue, Suite 200, Charlottesville, VA 22902.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" class="finTable" style="margin: 0pt auto 0pt 27pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Name of Beneficial Owner</b></p>
			</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>Amount and Nature of<br>
			Beneficial Ownership</b><sup><b>(1)</b></sup></b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><b>Percent of<br>
			Class(%)</b><sup><b>(1)</b></sup></b></p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;"><i>5% or Greater Stockholders:</i></p>
			</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".amt.B3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".amt.B4" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">Sabby Volatility Warrant Master Fund, Ltd.</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">10 Mountainview Road, Suite 205</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">Upper Saddle River, NJ 07458<sup> </sup><sup>(2</sup><sup>)</sup></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">467,819</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9.97%</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;"><i>Named Executive Officers and Directors:</i></p>
			</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".amt.B3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".amt.B4" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&nbsp;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">David Kalergis<sup>(3</sup><sup>)</sup></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">32,396</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">John L. Gainer<sup>(4</sup><sup>)</sup></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">41,262</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">Mark T. Giles<sup>(5</sup><sup>)</sup></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">70,296</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1.4%</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">Alan Levin<sup>(6</sup><sup>)</sup></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">17,509</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">Robert Adams<sup>(7</sup><sup>)</sup></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">20,670</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">William K. Hornung<sup>(8</sup><sup>)</sup></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">6,349</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">Thomas Byrne<sup>(9</sup><sup>)</sup></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">21,234</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 12pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12pt;">All current officers and directors as a group (7 persons)<sup>(9)</sup></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">209,716</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2.3%</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">

		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 27pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">*</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Less than 1%</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">7</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(1)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options and warrants currently exercisable, or exercisable within 60 days of June 30, 2019, are deemed outstanding for computing the percentage of the person holding such options or warrants but are not deemed outstanding for computing the percentage of any other person.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(2)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Based on a Selling Stockholder Notice and Questionnaire dated August 28, 2019.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(3)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Consists of (a)&nbsp;4,578 shares held directly by Mr. Kalergis directly, (b) 493 shares held by Mr. Kalergis&#8217; wife, (c) 2,551 shares held jointly with Mr. Kalergis&#8217; wife and (d)&nbsp;24,774 shares of common stock issuable upon the exercise of options exercisable within 60 days of June 30, 2019.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(4)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Consists of (a)&nbsp;4,389 shares held by the John L. Gainer Declaration of Trust dated February 19, 2008 and (b)&nbsp;16,873 shares of common stock issuable upon the exercise of options exercisable within 60 days of June 30, 2019. Dr. Gainer is a trustee of the revocable trust, and, as such, may be deemed to share beneficial ownership of such shares. Dr. Gainer expressly disclaims beneficial ownership of any such shares except to the extent of his pecuniary interest therein.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(5)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Consists of (a)&nbsp;294 shares held for the benefit of Mr. Giles in his individual retirement account, (b) 53,513 shares held by MTG Investment Holdings, LLC and (c)&nbsp;16,489 shares of common stock issuable upon the exercise of options exercisable within 60 days of June 30, 2019. Mr. Giles is the sole member of MTG Investment Holdings, LLC and may be deemed to be the beneficial owner of such securities. Mr. Giles disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(6)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Consists of (a)&nbsp;1,654 shares held by Mr. Levin directly and (b)&nbsp;15,855 shares of common stock issuable upon the exercise of options exercisable within 60 days of June 30, 2019.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(7)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Consists of (a)&nbsp;1,706 shares held directly by Mr. Adams directly, (b) 631 shares held jointly with Mr. Adams&#8217; wife, (c) 1,260 shares held for the benefit of Mr. Adams in his 401(k) retirement account and (d)&nbsp;17,073 shares of common stock issuable upon the exercise of options exercisable within 60 days of June 30, 2019.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(8)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Consists of shares of common stock issuable upon the exercise of options exercisable within 60 days of June 30, 2019.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">(9)</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Consists of (a)&nbsp;9,280 shares held by Mr. Byrne directly and (b)&nbsp;11,954 shares of common stock issuable upon the exercise of options exercisable within 60 days of June 30, 2019.</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">8</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>USE OF PROCEEDS</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">All shares of our common stock offered by this prospectus are being registered for the account of the selling stockholders. We will not receive any of the proceeds from the sale of these shares. We will receive proceeds from the cash exercise of the Warrants which, if exercised in cash with respect to all of the 1,382,913 shares of common stock underlying the Warrants, would result in gross proceeds of approximately $7.0 million to us. We will use any proceeds received by us from the cash exercise of the Warrants for general corporate purposes, including research and development activities, capital expenditures and working capital. We may also use all or a portion of such proceeds to fund possible investments in, or acquisitions of, complementary businesses, technologies or products, but we currently have no agreements or commitments with respect to any investment or acquisition. We cannot predict when or if the Warrants will be exercised, and it is possible that the Warrants may expire and never be exercised.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">9</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>DESCRIPTION OF CAPITAL STOCK</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Company Capitalization</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Our authorized capital stock consists of 1,000,000,000 shares of common stock and 30,000,000 shares of preferred stock, $0.001 par value, all of which remains undesignated. The following summary is qualified in its entirety by reference to our Certificate of Incorporation, as amended, a copy of which is filed as an exhibit to our previous filings with the SEC and incorporated herein by reference.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Common Stock</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Authorized</i>. We are authorized to issue 1,000,000,000 shares of common stock, of which 4,693,290 shares were issued and outstanding as of June 30, 2019. We may amend from time to time our Certificate of Incorporation to increase the number of authorized shares of common stock. Any such amendment would require the approval of the holders of a majority of the voting power of the shares entitled to vote thereon.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Voting Rights</i>. For all matters submitted to a vote of stockholders, each holder of common stock is entitled to one vote for each share registered in the holder&#8217;s name on our books. Our common stock does not have cumulative voting rights. At all meetings of the stockholders, except where otherwise provided by law, the Certificate of Incorporation or Bylaws, the presence, in person or by proxy duly authorized, of the holders of a majority of the outstanding shares of common stock entitled to vote constitutes a quorum for the transaction of business. Except as otherwise provided by law or by the Certificate of Incorporation or Bylaws, in all matters other than the election of directors, the affirmative vote of the majority of shares of common stock present in person or represented by proxy at the meeting and entitled to vote generally on the subject matter shall be the act of the stockholders. Except as otherwise provided by law, the Certificate of Incorporation or Bylaws, directors are elected by a plurality of the votes of the shares of common stock present in person or represented by proxy at the meeting and entitled to vote generally on the election of directors.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Dividends</i>. Subject to limitations under Delaware law and any preferences that may be applicable to any then outstanding preferred stock, holders of common stock are entitled to receive ratably those dividends, if any, as may be declared by our Board out of legally available funds.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Liquidation</i>. Upon our liquidation, dissolution or winding up, the holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities of our company, subject to any prior rights of any preferred stock then outstanding.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Fully Paid and Non-assessable</i>. All shares of our outstanding common stock are fully paid and non-assessable and any additional shares of common stock that we issue will be fully paid and non-assessable.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Other Rights and Restrictions</i>. Holders of common stock do not have preemptive or subscription rights, and they have no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to common stock. The rights, preferences and privileges of common stockholders are subject to the rights of the stockholders of any series of preferred stock which we may designate in the future. Our Certificate of Incorporation and Bylaws do not restrict the ability of a holder of common stock to transfer the holder&#8217;s shares of common stock.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Listing</i>. Our common stock is quoted on the Nasdaq Capital Market under the symbol &#8220;DFFN.&#8221; As of August 26, 2019, there were 518 record holders of our common stock.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Transfer Agent and Registrar</i>. The transfer agent and registrar for common stock is Computershare Investor Services, LLC, 250 Royall Street, Canton, Massachusetts, telephone number: 1-800-942-5909.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Warrants</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The material terms and provisions of the Warrants that are exercisable for the common stock registered in this Form S-1 are summarized below. The following description is subject to, and qualified in its entirety by, the forms of warrant which are incorporated by reference. You should review the forms of warrant for a complete description of the terms and conditions applicable to the warrants. See &#8220;Information Incorporated by Reference and Available Information&#8221; below.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>General</i>.&nbsp;&nbsp;&nbsp;&nbsp;Each selling stockholder received a warrant to purchase a certain number of shares of our common stock in accordance with the terms and conditions set forth in the applicable warrant.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Exercisability</i>.&nbsp;&nbsp;&nbsp;&nbsp;The Investor Warrants may be exercised at any time on or after their date of issuance, have an exercise price of $5.00 per share and are exercisable until November 29, 2024. The PA Warrants may be exercised at any time on or after their date of issuance, have an exercise price of $6.11875 per share and are exercisable until approximately the fifth anniversary of the issuance. All Warrants will be exercisable, at the option of each holder, in whole or in part by delivering a duly executed exercise notice accompanied by payment in full for the number of shares of our common stock purchased upon such exercise. The exercise price of the Warrant is subject to adjustment in the event of stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our common stock.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Exercise Limitations</i>.&nbsp;&nbsp;&nbsp;&nbsp;A holder of a Warrant will not have the right to exercise any portion of the Warrant if the holder (together with its affiliates) would beneficially own in excess of 4.99% (or, at election of holder, 9.99%) of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% upon notice to us provided that any increase shall not be effective until 61 days following notice to us.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Transferability</i>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to applicable laws, the Warrants are separately tradeable immediately after issuance at the option of the holders and may be transferred at the option of the holders.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>No Listing</i>.&nbsp;&nbsp;&nbsp;&nbsp;There is no established public trading market for the Warrants and we do not expect a market to develop. In addition, we do not intend to apply for listing of the Warrants on any securities exchange or trading system. Without an active market, the liquidity of the Warrants will be limited.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Fundamental Transactions</i>.&nbsp;&nbsp;&nbsp;&nbsp;In the event of a &#8220;fundamental transaction,&#8221; as defined in the Warrants and generally including any reorganization, recapitalization or reclassification of our common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding common stock, or any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common stock, the holders of the Warrants will be entitled to receive upon exercise of the Warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the Warrants immediately prior to such fundamental transaction.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In addition, in the event of a fundamental transaction (subject to certain exceptions), we or any successor entity shall, at the holder&#8217;s option, purchase the holder&#8217;s Warrants for an amount of cash equal to the value of the Warrants as determined in accordance with the Black-Scholes option pricing model.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Cashless Exercise</i>.&nbsp;&nbsp;&nbsp;&nbsp;If, at the time a holder exercises its Warrant, there is no effective registration statement registering, or the prospectus contained therein is not available for an issuance of the shares underlying the Warrant to the holder, and the holder is not able to sell the shares issuable upon exercise of the Warrant without limitations on volume pursuant to Rule&nbsp;144, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of our common stock determined according to a formula set forth in the Warrant. In the event of a cashless exercise, if we fail to timely deliver the shares underlying the Warrants, we will be subject to certain buy-in provisions.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">11</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Rights as a Stockholder</i>.&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in the Warrant or by virtue of a holder's ownership of shares of our common stock, the holders of the Warrants do not have the rights or privileges of holders of our common stock, including any voting rights, until they exercise their Warrants.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Amendments</i>.&nbsp;&nbsp;&nbsp;&nbsp;Amendments and waivers of the terms of the Warrants require the written consent of the holders of Warrants representing not less than a majority of the shares issuable upon exercise of the Warrants then outstanding and us, as well as any Warrant holder that would be disproportionately and materially adversely impacted by the amendment.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>No Fractional Shares</i>.&nbsp;&nbsp;&nbsp;&nbsp;No fractional shares or scrip representing fractional shares shall be issued upon the exercise of the Warrants. As to any fraction of a share which the holder would otherwise be entitled to purchase upon such exercise, we shall or shall cause, at our option, the payment of a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price of the Warrant per whole share or round such fractional share up to the nearest whole share.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Preferred Stock</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">As of June 30, 2019, no shares of preferred stock of the Company were issued or outstanding. Our Certificate of Incorporation authorizes our board of directors to provide for the issuance of up to 30,000,000 shares of preferred stock in one or more series. Our board is authorized to classify or reclassify any unissued portion of our authorized shares of preferred stock to provide for the issuance of shares of other classes or series, including preferred stock in one or more series. We may issue preferred stock from time to time in one or more classes or series, with the exact terms of each class or series established by our board. Without seeking stockholder approval, our board may issue preferred stock with voting and other rights that could adversely affect the voting power of the holders of our common stock. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of the common stock.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The rights, preferences, privileges and restrictions of the preferred stock of each series will be fixed by the certificate of designation relating to each series. A prospectus supplement relating to each series will specify the terms of the preferred stock, including, but not limited to:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">the distinctive designation and the maximum number of shares in the series;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">the terms on which dividends, if any, will be paid;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">the voting rights, if any, on the shares of the series;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">the terms and conditions, if any, on which the shares of the series shall be convertible into, or exchangeable for, shares of any other class or classes of capital stock;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">the terms on which the shares may be redeemed, if at all;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">the liquidation preference, if any; and</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">any or all other preferences, rights, restrictions, including restrictions on transferability, and qualifications of shares of the series.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The issuance of preferred stock may delay, deter or prevent a change in control.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We will describe the specific terms of a particular series of preferred stock in the prospectus supplement relating to that series. The description of preferred stock above and the description of the terms of a particular series of preferred stock in the prospectus supplement are not complete. You should refer to the applicable certificate of designation for complete information. The prospectus supplement will contain a description of U.S. federal income tax consequences relating to the preferred stock.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">12</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Anti-Takeover Provisions</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b><i>Delaware Anti-Takeover Law</i></b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We are subject to Section 203 of the DGCL. Section 203 generally prohibits a public Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (a) shares owned by persons who are directors and also officers of the corporation and (b) shares issued under employee stock plans under which employee participants do not have the right to determine whether shares held subject to the plan will be tendered in a tender or exchange offer; or</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">on or subsequent to the date of the transaction, the business combination is approved by the board and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2&#8260;3% of the outstanding voting stock that is not owned by the interested stockholder.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Section 203 defines a business combination to include:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">any merger or consolidation involving the corporation and the interested stockholder;</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">any sale, transfer, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">any transaction involving the corporation that has the effect of increasing the proportionate share of its stock owned by the interested stockholder; or</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;<b>Warrants and Stock Options Issued and Outstanding</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">As of June 30, 2019, the Company had the following warrants outstanding to acquire shares of its common stock:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align:bottom;width:57%;">&nbsp;</td>
			<td colspan="1" style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:12.2%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Outstanding</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:16.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Range of exercise</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>price per share</b></p>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:13.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Expiration dates</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:57%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Common stock warrants issued prior to 2016</p>
			</td>
			<td style="vertical-align:bottom;border-bottom: 1px #000000;;width:11.4%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">1,767</p>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:16.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">$562.50 - $735.00</p>
			</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:13.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:57%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Common stock warrants issued in 2017</p>
			</td>
			<td style="vertical-align:bottom;width:11.4%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">903,870</p>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:16.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">$33.30</p>
			</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:13.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">March 2022</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:57%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Common stock warrants issued in 2018</p>
			</td>
			<td style="vertical-align:bottom;width:11.4%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">1,181,375</p>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:16.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">$12.00 - $15.00</p>
			</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:13.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">January 2023</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:57%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Common stock warrants issued in 2019</p>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:11.4%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">1,382,913</p>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:16.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">$5.00 - $6.11875</p>
			</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:13.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2024</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:57%;">&nbsp;</td>
			<td style="vertical-align:bottom;border-bottom:double 3px #000000;;width:11.4%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:right;">3,469,925</p>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:0.8%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:16.3%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:1%;">&nbsp;</td>
			<td style="vertical-align:bottom;width:13.3%;">&nbsp;</td>
		</tr>

</table>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Additionally, as of June 30, 2019, we had 309,276 shares of common stock issuable upon the exercise of outstanding stock options under the 2015 Equity Plan at a weighted-average exercise price of $55.78 per share.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">13</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>THE SELLING STOCKHOLDERS</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">This prospectus covers an aggregate of up to 1,382,913 shares of our common stock that may be sold or otherwise disposed of by the selling stockholders. Such shares are issuable to the selling stockholders upon the exercise of the Warrants we issued to the selling stockholders in a private placement transaction.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The following table sets forth certain information with respect to each selling stockholder, including (i) the shares of our common stock beneficially owned by the selling stockholder prior to this offering, (ii) the number of shares that may be offered by the selling stockholder pursuant to this prospectus and (iii) the selling stockholder&#8217;s beneficial ownership after the completion of this offering, assuming that all of the shares covered hereby (but none of the other shares, if any, held by the selling stockholders) are sold.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The table is based on information supplied to us by the selling stockholders, with beneficial ownership and percentage ownership determined in accordance with the rules and regulations of the SEC and include voting or investment power with respect to shares of stock. This information does not necessarily indicate beneficial ownership for any other purpose. In computing the number of shares beneficially owned by a selling stockholder and the percentage ownership of that selling stockholder, shares of common stock subject to warrants held by that selling stockholder that are exercisable as of June 30, 2019, or exercisable within 60 days after June 30, 2019, are deemed outstanding. Such shares, however, are not deemed outstanding for the purposes of computing the percentage ownership of any other person. The percentage of beneficial ownership calculations below are based on 4,693,290 shares of common stock outstanding as of June 30, 2019.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The registration of these shares of common stock does not mean that the selling stockholders will sell or otherwise dispose of all or any of those securities. The selling stockholders may sell or otherwise dispose of all, a portion or none of such shares from time to time. We do not know the number of shares, if any, that will be offered for sale or other disposition by any of the selling stockholders under this prospectus. Furthermore, the selling stockholders may have sold, transferred or disposed of the shares of common stock covered hereby in transactions exempt from the registration requirements of the Securities Act since the date on which we filed this prospectus.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The actual number of shares of common stock included in the registration statement of which this prospectus forms a part includes, in accordance with Rule 416 under the Securities Act, such indeterminate number of additional shares of our common stock as may become issuable in connection with any proportionate adjustment for any stock splits, stock combinations, stock dividends, recapitalizations or similar events with respect to common stock.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">To our knowledge and except as noted below, none of the selling stockholders has, or within the past three years has had, any position, office or other material relationship with us or any of our predecessors or affiliates.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">

		<tr>
			<td style="vertical-align: top; width: 32.3%;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;border-bottom:solid 1px #000000;;width:27.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Beneficial Ownership Before</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>This</b><b>&nbsp;</b><b>Offering</b></p>
			</td>
			<td style="vertical-align:top;width:14.6%;">&nbsp;</td>
			<td colspan="2" style="vertical-align:middle;border-bottom:solid 1px #000000;;width:26.5%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Beneficial Ownership After</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>This </b><b>Offering</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 32.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Selling Stockholder</b></p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Number of</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Shares Owned</b></p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Percentage</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>of</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Outstanding</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Shares</b></p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Shares</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Underlying</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Warrants</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Offered</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Hereby</b></p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Number of</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Shares</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Owned</b></p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Percentage</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>of</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Outstanding</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Shares</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 32.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Armistice Capital Master Fund, Ltd.</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">510 Madison Ave, Floor 7</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">New York, NY 10022</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">439,020&nbsp;(1)&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">4.99% (3)</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">439,020&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#8211;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#8211;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 32.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Sabby Volatility Warrant Master Fund, Ltd.</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">10 Mountainview Road, Suite 205</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Upper Saddle River, NJ 07458</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">906,839 (2)&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">9.97% (3)&nbsp;</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">439,020</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">467,819</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">9.97%</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 32.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Anson Investments Master Fund LP</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">155 University Avenue, Suite 207</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Toronto, Ontario, Canada</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">M5H 3B7</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">439,020&nbsp;(1)&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">4.99% (3)</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">439,020&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#8211;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#8211;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 32.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Michael Vasinkevich</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">c/o H.C. Wainwright &amp; Co., LLC</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">430 Park Avenue, 4th Floor</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">New York, New York 10022</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">76,256 (1)&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">1.6%</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">42,475&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">33,781</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">*%</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 32.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Noam Rubinstein</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">c/o H.C. Wainwright &amp; Co., LLC</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">430 Park Avenue, 4th Floor</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">New York, New York 10022</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">36,509 (1)&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">*%</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">20,744&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">15,765</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">*%</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 32.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Mark Viklund</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">c/o H.C. Wainwright &amp; Co., LLC</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">430 Park Avenue, 4th Floor</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">New York, New York 10022</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">1,976 (1)</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">*%</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">1,976&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#8211;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#8211;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 32.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Charles Worthman</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">c/o H.C. Wainwright &amp; Co., LLC</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">430 Park Avenue, 4th Floor</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">New York, New York 10022</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">1,158 (1)</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">*%</p>
			</td>
			<td style="vertical-align:middle;border-bottom:solid 1px #000000;;width:14.6%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">658&nbsp;</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">658</p>
			</td>
			<td style="vertical-align: middle; border-bottom: 1px solid rgb(0, 0, 0); width: 13.3%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">*%</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">This table and the information in the notes below are based upon information supplied by the selling stockholders, including reports and amendments thereto filed with the SEC on Schedule 13G and other information available to us.</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 1;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 29pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(1)</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">All shares held are in the form of the Warrants or other warrants to purchase common stock of the Company.&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 29pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 29pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">(2)</p>
			</td>
			<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">Includes 439,020 shares that may be received upon the exercise of Warrants.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 1;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="width:29pt;vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">(3)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; margin-right: 0pt; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; font-size: 10pt; line-height: 1;">The Warrants are not currently exercisable by the holders if such exercise would result in the holder owning greater than 4.99% of the Company&#8217;s common stock. As such, the shares that would be received upon the exercise of the Warrants are not included for purposes of calculating these percentages.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: 1;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">* Less than 1%</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">14</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>PLAN OF DISTRIBUTION</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The selling stockholders, including their transferees, donees, pledgees, assignees and successors-in-interest, may sell, transfer or otherwise dispose of any or all of the shares of common stock offered by this prospectus from time to time on The NASDAQ Capital Market or any other stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market price or at negotiated prices. The selling stockholders may use any one or more of the following methods when selling shares:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an exchange distribution in accordance with the rules of the applicable exchange;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;privately negotiated transactions;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;broker-dealers may agree with the selling stockholder to sell a specified number of such shares at a stipulated price per share;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a combination of any such methods of sale;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; or</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:28.8pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any other method permitted pursuant to applicable law.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The selling stockholders may also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Broker-dealers engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling stockholders or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser in amounts to be negotiated. The selling stockholders does not expect these commissions and discounts relating to its sales of shares to exceed what is customary in the types of transactions involved.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The selling stockholder may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out its short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus, as supplemented or amended to reflect such transaction.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The selling stockholders and any broker-dealers or agents that are involved in selling the shares may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each selling stockholder has informed us that it does not have any agreement or understanding, directly or indirectly, with any person to distribute the common stock.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Because the selling stockholders may be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act, it will be subject to the prospectus delivery requirements of the Securities Act. In addition, any securities covered by this prospectus which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than under this prospectus. The selling stockholders have advised us that there is no underwriter or coordinating broker acting in connection with the proposed sale of the resale securities by the selling stockholders.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:3.6pt;margin-top:0pt;text-align:justify;">The shares will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the shares may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">15</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale shares may not simultaneously engage in market making activities with respect to our common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of shares of our common stock by the selling stockholders or any other person. We will make copies of this prospectus available to the selling stockholders and have informed the selling stockholders of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We are required to pay certain fees and expenses in connection with the registration of the shares of common stock issuable upon exercise of the Warrants. We have agreed to indemnify the selling stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We will not receive any proceeds from the sale of the shares by the selling stockholders.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">16</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>LEGAL MATTERS</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The validity of the securities being offered by this prospectus will be passed upon for us by Dechert LLP, New York, New York.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>EXPERTS</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The consolidated financial statements of Diffusion Pharmaceuticals Inc. as of and for the years ended December 31, 2018 and 2017, have been incorporated by reference herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. The audit report covering the December 31, 2018 consolidated financial statements contains an explanatory paragraph that states that the Company has suffered recurring losses from operations, has limited resources available to fund current research and development activities, and will require substantial additional financing to continue to fund its research and development activities that raise substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>WHERE YOU CAN FIND ADDITIONAL INFORMATION</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We have filed with the SEC a registration statement on Form S-1 under the Securities Act, with respect to the securities being offered by this prospectus. This prospectus does not contain all of the information in the registration statement and its exhibits. For further information with respect to us and the securities offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We file electronically with the SEC annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements and other information and amendments to those reports filed or furnished pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934. The SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Copies of these reports, proxy and information statements and other information may be obtained by electronic request at the following e-mail address:&nbsp;<u>publicinfo@sec.gov</u>.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We make available, free of charge and through our Internet web site at www.diffusionpharma.com, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to any such reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. We also make available, free of charge and through our Internet web site, to any stockholder who requests, the charters of our board committees, our Corporate Governance Guidelines and our Code of Business Conduct and Ethics. Requests for copies can be directed to Investor Relations at (434) 220-0718. The information set forth on, or connected to, our website is expressly not incorporated by reference into, and does not constitute a part of, this prospectus.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">17</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The SEC allows us to incorporate by reference information into this prospectus. This means we can disclose information to you by referring you to another document we filed with the SEC. We will make those documents available to you without charge upon your oral or written request. Requests for those documents should be directed to Investor Relations Department, Diffusion Pharmaceuticals Inc., 1317 Carlton Avenue, Suite 200, Charlottesville, Virginia 22902, Attention: Secretary, telephone: (434) 220-0718. This prospectus incorporates by reference the following documents (other than any portion of the respective filings furnished, rather than filed, under the applicable SEC rules) that we have filed with the SEC but have not included or delivered with this prospectus:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">our <a href="http://www.sec.gov/Archives/edgar/data/1053691/000143774919005256/dffn20181231_10k.htm" style="-sec-extract:exhibit;">Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the SEC on March 19, 2019;</a></p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">our <a href="http://www.sec.gov/Archives/edgar/data/1053691/000143774919009285/dffn20190331_10q.htm" style="-sec-extract:exhibit;">Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2019</a> and <a href="http://www.sec.gov/Archives/edgar/data/1053691/000143774919016051/dffn20190630_10q.htm" style="-sec-extract:exhibit;">June 30, 2019,</a> filed with the SEC on May 9, 2019 and August 8, 2019, respectively;</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">our <a href="http://www.sec.gov/Archives/edgar/data/1053691/000143774919001064/dffn20190118_8k.htm" style="-sec-extract:exhibit;">Current Reports on Form 8-K filed with the SEC on January 18, 2019,</a> <a href="http://www.sec.gov/Archives/edgar/data/1053691/000143774919010905/dffn20190525_8k.htm" style="-sec-extract:exhibit;">May 28, 2019</a> and <a href="http://www.sec.gov/Archives/edgar/data/1053691/000143774919011940/dffn20190613_8k.htm" style="-sec-extract:exhibit;">June 13, 2019</a> (in each case, other than the portions of such reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items);</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#8226;</p>
			</td>
			<td>
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">our <a href="http://www.sec.gov/Archives/edgar/data/1053691/000143774919008328/dffn20190429_def14a.htm" style="-sec-extract:exhibit;">Definitive Proxy Statement on Schedule 14A filed with the SEC on April 30, 2019;</a> and</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">&#8226;</p>
			</td>
			<td>
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><a href="http://www.sec.gov/Archives/edgar/data/1053691/000143774916041352/dffn20161108_8a12b.htm" style="-sec-extract:exhibit;">the description of our common stock included in our amended registration statement on Form 8-A filed on November 8, 2016 under the Exchange Act,</a> and any amendment or report we may file with the SEC for the purpose of updating such description.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Any statement contained in any document incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or any prospectus modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We also incorporate by reference any future filings, other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items, made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, in each case, other than those documents or the portions of those documents deemed to be furnished and not filed in accordance with SEC rules, until the offering of the securities under the registration statement of which this prospectus forms a part is terminated or completed. Information in such future filings updates and supplements the information provided in this prospectus. Any statements in any such future filings will be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Because we are incorporating by reference future filings with the SEC, this prospectus is continually updated and later information filed with the SEC may update and supersede some of the information included or incorporated by reference in this prospectus. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this prospectus or in any document previously incorporated by reference have been modified or superseded.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We will provide without charge to each person, including any beneficial owners, to whom this prospectus is delivered, upon his or her written or oral request, a copy of any or all reports or documents referred to above which have been or may be incorporated by reference into this prospectus but not delivered with this prospectus, excluding exhibits to those reports or documents unless they are specifically incorporated by reference into those documents. You may request a copy of these documents by writing or telephoning us at the following address:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Diffusion Pharmaceuticals Inc.</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">1317 Carlton Avenue, Suite 200</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Charlottesville, Virginia 22902</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(434) 220-0718</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Attention: Investor Relations</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">18</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 0.75pt;text-align:center;">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div style="text-align: center;"><img alt="" src="logo9.jpg"></div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 0.75pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;<br>
&nbsp;<br>
&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>1,382,913 Shares of Common Stock</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Issuable upon Exercise of Outstanding Warrants</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><br>
&nbsp;<br>
&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><br>
<br>
&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>PROSPECTUS</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;<br>
&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;<br>
&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>October 10</b><b>, 2019</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>a01.jpg
<TEXT>
begin 644 a01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" %0 E$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW=N[76GQ2RN[[$=/N;ODV-_$[UQ/_!XML_X=C^%/,7?'_P + LMRK_V#]1H
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MG^\:SOV=/^">?PM_9@_9U\0_"C0-#:[\"^*;S4;S5=.U6=KU+TWW^O1R_P#
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M+*OVH8*JJHL6X)U>2ICC<PE+DYOR.B?#W!D,-/%3H>Y%\O-[V][::ZGTN?\
M@Y*U4S!O^%1V>!V_X2(__(].'_!R;JHDS_PJ.S^G_"1-_P#(]?,WP4_96^%G
MBSX)?$;7?%E_\4=*\1_"*")?$UC816'DS2O</#MM?-&_Y'3_ ):[*TO!O_!.
M32/BW8?!^]\-^(M8L-+^(]KKFKZA<ZI#%*^CZ?IUP$W*L?WI765/EY3?_L\4
MUB\QE\,OR]#.ID7!D')5*#5M/M_R\WY:GT/_ ,1)NJ[L_P#"I+/_ ,*(\?\
MDO2-_P ')NJL/^226G_A1G_Y'KY1M_V7?AW\9/@EXJ\:?"_Q!XT=/ =[81:Q
M8^);:UCFNK.[E\I;BU:#[O?]V_IV[^P>//\ @D-HWAWX]'1=,\5:SJ?@N/3=
M26ZU#9$+[2M7M+<7'V27Y-NV6%UE5OXEW_6FL3F3^&7Y&<LFX)IM0J4N66O\
MW1)]^S1Z?_Q$FZM_T2.U_P#"B;_Y&H_XB3M6_P"B1VO_ (43?_(U?F+;W'VB
MVB?_ )Z)OIU<7]M8O^8^OAX9<.2CS?5_Q?\ F?HW\3?^#GW6/AQX U37/^%-
M6=X=-A67R/\ A)G7?ET3[WV7_:KQC_B,^UK_ *-XT[_PLW_^0J^$OVF?^2$^
M)O\ KW3_ -&I7QI7T^1XBK7IRG49^#^)F18'*LPAA\##EC)7Z_J?MQ_Q&?:U
M_P!&\:=_X6;_ /R%4UO_ ,'EOB+4&VVW[.%O<M_TP\72S?\ H-E7X@U^S7_!
M :7QO9?\$:_VH[CX;>-/#?PZ\<KXGM?[,\2Z]>Q6=AI3_9['<TMQ*K(B[-Z_
M.GWWKVS\X-[_ (C/-9,[1M^SOIT<L9VNC>,WW+_Y)4?\1GVM?]&\:=_X6;__
M "%5+]K7X>_"7_@J1^TI^R7\!_$GQ/\ "/CGXY2Q:E%\2?B'\.;>W>&5(=/F
MN(H?-V>5*[S1)_#\G[UMB>;LKQ+3?^"%WP_\1_M,_L]>#+C7?BW\.I/C3>:[
M;W_A/Q=;:?\ \)1HL&GVDTT6H1>4GDM;S/%L_?1(_P _R[J />O^(S[6O^C>
M-._\+-__ )"H_P"(S[6O^C>-._\ "S?_ .0J^5O$W_!&+P_=_M)R>&8S\8/A
M1X.\(>"-4\?^,=4\?P:/>ZDNEV4J)OL(-.E=)79VV_O67O7 _L__ +'/[//[
M:/Q2\6:1\,=?^.&FZ;X-^''B'QE=R>*K?2EN;FZT]86MUB^S[T6&7?+O1_G3
M8FUZ /N?_B,^UK_HWC3O_"S?_P"0J/\ B,^UK_HWC3O_  LW_P#D*OS/_9&_
M8RT7]HW]BWX^_$_4M9UC3]4^$4?AMM/L;5(OLU]_:=^;27S=R;_D3YDV5]F_
M'?\ X-W/#/PT_:;OM%\/_$'Q/XC^&5CX<UY[W6%M[?\ M+1?$FE67VW^S+KY
M-FR:W>*5&V;W3?\ W=] CV/_ (C/M:_Z-XT[_P +-_\ Y"H_XC/M:_Z-XT[_
M ,+-_P#Y"KY$T+_@C5X:U>#X>Z]?_$'6- \!W'P&M?C7X\U5["*[N],65G7[
M%80)M\QG=/D\Y_[^[^Y7EWP0_9(^$?[<7[;_ ,+_ (7_  5U#XM:?X?\1RRO
MXHO?&<6F?;-*M;='EN+JW^R_)L^SH_W_ ./8GST#/T,_XC/M:_Z-XT[_ ,+-
M_P#Y"H_XC/M:_P"C>-._\+-__D*OEGP[_P $9?!7C#_@J'\(/A/I7C3QA-\'
M_C?X,?QEX=\2R6MNNL>4FGW%P\4L6SREE26WV.FS[CI7YWW">5+,O]QW6@1^
MVW_$9]K7_1O&G?\ A9O_ /(5'_$9]K7_ $;QIW_A9O\ _(5?B/10,_I$_95_
MX.0]3_:7^%+>(Y/A%9Z,RZA+8_9U\2M-]S9\VXVZ_P!^O2_^'Y&H8_Y)O:?^
M#UO_ )'K\@?^"6O_ ":_-_V';K_T&&OH^OTW*\@P-7#0J58>])>9\?C,QKQK
MRA!GW>O_  7)U ?\TVL__!ZW_P CTH_X+DZC_P!$T@/_ '&V_P#D>O@^O6_V
M"HUD_;+^'*LN5_M/_P!HS5OB\@RZE0G6]G\/FS"CF.)G-0YCZ6G_ ."X6IVN
MWS/AC%'O^YOUIEW_ /DO2?\ #\O4/^B:V?\ X/6_^1ZZSXS?$N'P;J/QA@^*
M_CGP7XC\'WXGM_#?A:WDANM4LY<'8A55WQM_O9V?>WIMKP;PO_P33UCQ9XA^
M%[6 UF^\*>+]"LM2UW5$FM%DTR65'=DB1_G94^3^!_OUX>#CE,X\V(I<OS9W
M5*N+C*U.5STS_A^3J!_YIK9_^#UO_D>C_A^1J'_1-[3_ ,'K?_(]>*_LX_L8
MZ5\8I/$C:UK>I:-;0^(W\+:%+#"I2]OMDS_O?[J;(D^Y_&]4?V<?V2M-^*7@
MKQ)J6L/XHU36?#FI?V;-X7\-?9/[414^]=.EP_S*C_)L3Y_DKOE@\DCS>[\/
MKU,5B,=+E]X]X_X?D:A_T3>T_P#!ZW_R/44W_!;O4A)OC^'%F)-NW_D-,W_M
M*O*OA7^Q5HOC3X#6WC&:R^).J37&I7]DUII"Z?#)816[NBM<)<,GS_WU3^/?
M7S]X&\3V_@[Q=IVKW&D:;K]O92^:^GZ@F^SO/]F5/[M;T\IRNNI>QI_#YLF>
M-Q=)Q4I?$?:=C_P7#O5#,OPZLY)&?YF77?\ [55G_A^1??\ 1-K3_P 'K?\
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M;XF0[?F1_N[TX%/ZYG/-R\_Y=33_ %=\,U2C5]@]8REO/:%[]=U9Z;GM+?\
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M1"VK?]$PM?\ P?-_\8H'_!POJV/^286G_@];_P",5^<M%1_K-F/\_P"1V_\
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M1?GNG2=_F7?\FQ/G^2O0E@LDCS:?#ZF/M\<[:GO'_#\G4/\ HF]I_P"#UO\
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MF^#]*TSX>6]W;Z#X=L;5K?2K/[5$\4KLGF^;)*^[[S-CK7[J?\,C?"V)"?\
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M%9%Q<7$'[R>%MG_3.7_5U:CO_(@3S6#,_P!W;_'5<Q)=HJ**X$H]&_NM4M:
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M_?CU_P!%&\#_ /@5IO\ A1_K7AOY6<__ ! 7.?\ H(I??_\ :G[5?\)#;?\
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M_P# K3/\*M6'[=/QWG7>WQ(\&;ON?\?&F?X4?ZW8;^61$O G.(_\Q%+[W_\
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M32;=;>RC/WI)6V?*O_H?\%:4N+L-5G[.$)'G9EX"9SE^'EB<96I1A#XI7?\
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MY\/;C.][G27^[/\ QP_[#_\ Q=(K<[ZBJ6D:Q#JMJKQMNJ[6A 4444 %%%%
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MG\^*TD<?O%^SI/\ :.5M?*_N?+G?GM7EEDEG=ZWY=]?FRMV9]T\<'VAD_P"
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MIH==M?".F^(FOFU(2)-=3/$DMKY&W^'>SYW;EV"N,_X1OP=_T-EU_P"$\?\
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M]Z.CV<NP1E2_F18^V21W/F+\C5)'82:@K2+LW53\U?45<T^X:-]L;*V]-_\
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M6P/RP#^_+C_T'^.OSP^JL;'Q1^+VB_L^^%D:?_2K^5/]"L(G^>;_ &O]E/\
M:KY\T3_A(_C9XY_MC5IGD<_)%$ORPVR?W56H?!7P_P!9^*WBF36-9N)KZ^O&
MW2S2?^@)_<3_ &*^GOAM\++?PO9K^[3=2*-+X<^'Y-'T:..2NHIL:*B_+3JT
M,PHHHH \1U#]@[X7W=R[KX$\(C>S-M&DV_\ \34'_# GPS_Z$;PE_P""F#_X
MBO<2*,5Q_4,/_*>PN(,Q6GMY?^!/_,\._P"&!/AG_P!"-X2_\%,'_P 11_PP
M)\,_^A&\)?\ @I@_^(KW+\J/RH^HX?\ E'_K%F7_ #_E_P"!,\-_X8$^&?\
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M\+5<ANUG7<I_6G]0P_\ *+_6',?^?\_O9X?_ ,,#_"^!L-X)\(;F_O:5;_\
MQ%2?\,!_#+_H1O"7_@HM_P#XBO9[J,^8S89OEV_+4MC;FTM(X]V[:,9J8X2A
M_*5_K#F7_/\ G][/$O\ A@/X9_\ 0B>$_P#P4V__ ,11_P ,!?#/_H1/"?\
MX*;?_P"(KW+%&*OZG1_E#_6+,O\ G_/_ ,"?^9X;_P ,!?#/_H1/"?\ X*;?
M_P"(H_X8"^&?_0B>$_\ P4V__P 17N6*,4?4Z/\ *'^L69?\_P"?_@3_ ,SP
MW_A@+X9_]")X3_\ !3;_ /Q%'_# 7PS_ .A$\)_^"FW_ /B*]RQ1BCZG1_E#
M_6+,O^?\_P#P)_YGAO\ PP%\,_\ H1/"?_@IM_\ XBC_ (8"^&?_ $(GA/\
M\%-O_P#$5[EBC%'U.C_*'^L69?\ /^?_ ($_\SPW_A@+X9_]")X3_P#!3;__
M !%'_# 7PS_Z$3PG_P""FW_^(KW+%&*/J='^4/\ 6+,O^?\ /_P)_P"9X;_P
MP%\,_P#H1/"?_@IM_P#XBC_A@/X9_P#0B>$__!3;_P#Q%>Y8HQ1]3H?RA_K#
MF7_/^?\ X$_\SP[_ (8#^&?_ $(GA+_P46__ ,14=Q_P3\^&,R;?^$&\)?\
M@GM__B*]UQ2[<FCZG1_E%_K!F/6O+_P)_P"9XC\/_@3#^S4T[>$--L]/TBXE
M\VZTRUA2&"5O[R*OW6_VJ[R>PTWXB:9]JM"ZR(_^Y-"__LM=C<1+.FTUQGB#
MPG/H^H?VEIDGDW.?G7^"9?[K5TJ/+L>7.I.K/FD6M(\1WVB#[/J4,USM^[<Q
M)\[_ .\M5=2MKSQ[?!90T&F(WRP?QS?[;_\ Q%7='^(&F:C#MO'CL+N/_6PS
MOL_[Y_O+7BW[0G[45Q<3OX=\%3'<WR76IQ?P?[,'_P 7_P!\YI$FK\>?VF8?
MAN6\.>%O)N]=^Y<3?>AT[_XJ7_9_A_BKS7X3_!>^\8:PVH:@TUU<7$OFRSR_
M.\S_ -]ZT?@A\ )+R47%Q&_]_P":OICPAX-M_#UFJQQK0,I^!/ %OX:LPJQI
MNKJONK2T5H9A1110 4444 ?)6I?\%@/@E!>.D7C6W=%9]I^PW7_QJJ__  ^)
M^"__ $.,/_@%<?\ QJOQJL([)M<8:FUZEEN?S&LXU>5/]U694_\ 'JW/L_@/
M_G\\;_\ @%:?_':_+H\88R6O+'^OF?VE7^CWP]0GR.K6^Z_Y1/UY_P"'Q/P7
M_P"AQA_\ KC_ .-4?\/B?@O_ -#C#_X!7'_QJOR(^S> ?^?SQQ_X!6?_ ,=H
M^S> ?^?SQQ_X!6?_ ,=JO];\;_+'^OF<_P#Q /AS^>O]W_VI^N__  ^)^"__
M $.,/_@%<?\ QJC_ (?$_!?_ *'&'_P"N/\ XU7Y$?9O /\ S^>./_ *S_\
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MM'V;P#_S^>./_ *S_P#CM'^M^-_E7]?,?_$ N'?YZ_W?_:GZ[_\ #XGX+_\
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M]\$:=J,$<C9@DUQ(5E_X%&RO6TG_  3C^)B#_DB_AL_7Q9<?_'J_$*>28O\
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M67'_ ,>H_L;&?RR^Y_Y#_P"(F\.?\_(_^!4__DCY+\M?3OOI([=8RVU57?\
MW:^M?^'<_P 3?^B+^'/_  J[C_X]1_P[B^)G_1&/#?\ X5EQ_P#'J7]BXO\
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MQ_\ 'J/^'</Q-_Z(UX<_\*RX_P#CU']BXK^1_<_\@_XBCD'_ #]C_P"!P_\
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MM<;\+_B/=>-_B1\2M)NK>WB@\(:Y;Z9:O%N+SQ2:58W;,_\ M[[IUX_A1:]
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M,:7FORI_H5E$_P _^\W]U/\ T.H/CY^TQ:?#6!M+T&.'4M?E'1?GBLU_O/\
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M_F'_ !!_BS_H$E]Z_P S]+<GU_049/K_ "K\TO\ A_KI'_0C^(__  *MZ/\
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MFRG^+&VKE%% $4DJIC_V6G1N)$!7I23VZSCYJ=C8N!0 ZBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^:VT>T76<WZW4MKN?>MJZI
M*_\ NLRLG_CM:PNO!O\ SX^+_P#P86W_ ,CUS]Y_Q\R_[]?4NK?!+P0G[.%M
M=II6A7&MCX=6GB=HK9KI=:%U+/Y37C,S>2UHO5HE^?C[O0U^$X+#SK1ER?9/
M]->+L\PN65*<L0I_O)<ON/\ /5'SU]K\&?\ 0/\ &'_@PM?_ )'H^U>#<_\
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M]C?2/'7Q"N-'\/II'AB&?Q)I6E1,('S DN@?;I=OS_-N96VIMW-*R_,M=/\
M9F)^Q8\C_7O*5)1K>TC&U_B;TNDMI/OZZ.Y\U?:O!^?^/+Q=C_K^MO\ Y'I?
MM7@[_GQ\7?\ @?:__(]>\^ ?V4O#-KX5U?6KH:_>Z5K?@G5-4L+.^TH#7]*N
M+6^@A9UME?:Q?>Q1MVT_-Z4Y/V,["#P9K&DV45UK.KZIJ7AF;2II+=;?5;"U
MOHKB2:&6-I-L<H2)=Z.VSA6I?V;B?+\"Y<=Y'&4XIS]V27VEHW%-[]'+6^IX
M)]K\&_\ /AXO_P#!A;?_ "/5;5Y?#3V,HL;+Q%%=?\LFNKR!XO\ @:K"K_\
MCU>ZO^POI)\=Z=IL/BK4+FWUW1?[3TB!;6);J^N/-:#[/YK,MNK<%E9V7?\
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M!H=/C*W&G>';E-IG/\,MTOITVQ?]]?W!^BNHZF^HWG]DZ+&@8)\S?\L[9/\
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M=]U?]VG_ &=+<GRT56_O4 5;6S9;W[1(W\'W=E78[?9M&[Y1_#21IO;YM_\
MP*E3S-R_^/5F GF?O>%_\=I_W/\ >:G2/L6JFIZ@MI9M(1\WW45N[4 2_P >
M[YZ;>0+>0M'-'N2F)IN4_>32EO[R_)5>TN9AJ<EO<8;:OFQLM %>32)+=?\
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M\-;DU[X9:K%K]KM3S&\I/];\G^S\K_[B-7TUIFL6^N6*W%K*D\+]&4U\5_\
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M)<PX^9T_.@#.TN1IM1D\SY6B7"KN^_\ [5:]9MG;-]N\UH]OWOFW?>K2JH;
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7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>a02.jpg
<TEXT>
begin 644 a02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" %  CH# 2(  A$! Q$!_\0
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M*-L=XUB4NV0!D@%LHH/3^OZ_S'?M^GR_KU/UTMM;U$M"IN)&=@F>$;=D(V[
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MOA-\.X_&"JEH1=S7GE6),,DA*Y#R7#,0^&Q&ORC#8->O]?U_GV#5;[?U^?\
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M>(=.NGT^_OYK-&F\MXU+A6;>T *!@BJ&S@J/5[G]O3XF>$OVJ?V7?AWJ.K^
M?$&F?%3PY_;'B/5-)LBD%_LDD:*6TR/,1=BQE<J!PVTYQA7:6HKM+7]/ZV_4
M^YH/$=[LB?SYI%,8GVAHV+QYC48*Q_-N*.?D!)$N$5LJ8W0Z[?1-&'NI) H+
M.P,1\Q(A&9'&$P0VU@,'Y?-^8J2JI^<'PF_;X_:R_;9T7Q?\1?@MX,^&5SX!
M\,Z\^B:?X<U)R-1\2;#^\?[3(=BOM\J1N1@8QYG4>G?\%.OV^_B5^S/HWPY\
M+_#+P[H\_P 7/'J7.K7&C:BOVXZ9!:PR/,Q((,I5@D2R@!6$?!8,FUNZ=OZ_
MK^NQ3NG;\_P_X/SZ6/M&VUO42T*FXD9V"9X1MV0C;L",%@%1\JH#'S<E8E*E
M&P>([W9$_GS2*8Q/M#1L7CS&HP5C^;<4<_("2)<(K94Q_G_\6/\ @KSX@U3]
ME;]G[4?A9H6B:E\2_P!H&ZCTVTAU-_\ 0-)NX##%,'0?.<7&/+(&U06QD@5Z
MG\-M3_;'E\(?$KPYXPT#X=0^*=)L_/\ "'BNS\MM)\07>59[6:U8JZ"3*!9&
MV89,$DYHU_K_ (82OO\ U^7_  R[:'U?#KM]$T8>ZDD"@L[ Q'S$B$9D<83!
M#;6 P?E\WYBI*JA;:WJ):%3<2,[!,\(V[(1MV!&"P"H^54!CYN2L2E2GYM?L
MW_\ !6+XP?MJ?%'X<_#/P+X7TKP_\0=--Q-\6+W6].E:UT5H9DA_=)N 24@X
M7<#\[(@)5&#>Z?\ !7K]M#Q;^PI^SEX?\5>"(M*EU'6/$]IHK)J-BT\;V_EE
MDDVDAEE1D4?=P"6! 8+DU_K_ (8->_\ P_W'U?!XCO=D3^?-(IC$^T-&Q>/,
M:C!6/YMQ1S\@)(EPBME3&Z'7;Z)HP]U)(%!9V!B/F)$(S(XPF"&VL!@_+YOS
M%255/ST^(7_!8;4O@5_P5AU_X0>.H=$M?A1:W$&F+JZ6Y^T:7=W<44EO/<.#
MAX?,/EONP ,,YRHW>T_\$E/VP/&/[;OP2\1>)_'4&F0:IIOC2\T6 :=;_9XY
M8XO+PI!)#2JF/G7+!(S]S.6-;?U_7J%W:_\ 7]=_^&/J*VUO42T*FXD9V"9X
M1MV0C;L",%@%1\JH#'S<E8E*E&P>([W9$_GS2*8Q/M#1L7CS&HP5C^;<4<_(
M"2)<(K94Q_FQX=_X*T_&"Y_97_:'\;6GA7P[XKUCX5>-(?#NEQ6MA((+:UW2
M#[7<+$3YGE8C. 3M8>X-;O[$W_!57Q!\2]"^)>L>+O&/PH^(WA3P1X6E\1/=
M^'TFT;5VF6,2-;/I\H#LAEV1F924W*OS$/BC7J'KL?H9#KM]$T8>ZDD"@L[
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M,/=22!06=@8CYB1",R.,)@AMK 8/R^;\Q4E50MM;U$M"IN)&=@F>$;=D(V[
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MY'EJ0 L<F<A=WF9_=J5*?!7_  51_P""D?C#X(>'O@U>?!36_#CWGC?X@?\
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M[3I;KXJ^ SX,>W2QE,MK/'#:)-<R2$[C%F#>0NW#,F&);#?8-P#<ROYJA'F
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M;$\DC@2+L,KL"^YNNXLP@;]V#E/+A ">6Q"P[9'9(@T2RSR-&J ,T3'&=@W
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M^QGF=C;&X< EHEF:0XXD7,:MD*XX?RCE]Y_<_*90@-2K*8W5 VXPR2,B-*"
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MMTXZ].GJ*!\?K<X_XI7Q[RQ4?\2"?J,^W3CKTZ>HHL^P<LNS.]HK@S\?;4.
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M,OQ'U?Q%I&O7GA4PZ-X*U+4HKS5[:W2Y?3K>6&)DEN6B?<L:G)"-TXS1M_\
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MZ1!>(ML^ZWMWO8;1+CR5 6-T5P)8P5?.XD_;M%&^H;N["BBB@ HHHH ****
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M_7]?D?PO](J$8\824%9>SI_DPHHHKZ$_"@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \WT;Q#X[\:ZSK[:;?>$K'3M,U2;3[9;C39[B618U&69EN$&=Y
MVXV]B>V#H#3/B3C_ )#G@CI_T [K^Z#_ ,_?][(^@SWP/C?_ (*U_MX^,?\
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M\0,4$;'PA>@@)(PP;RS9QGRU4'<8^N&;;EB2=J_M)7XJ_P#!O,J1_MS:J0J
M-X-OD5A\_P!VYT_ #F+)XSD[@3U(XQ7[55^B<*JV 7JS^$?I&7_UP;>_LJ?Y
M,****^D/P<**** "BBB@ HHHH **** /C;_@M;X!\4>/_P!G3PY'X2TWQSKV
MK:9KQOX]$T/3+J_T_7F2SN=EGJ0M+FWN(;=Y"C+/')^ZECB)&#7"?L.^!/B+
MX6_X*:>,=9U;P#XYCT+Q5H(FU35/$$MS#%X-NHK?3XXM'L9Q<O:ZK9$B8I(L
M*R1R13,S$.,_H)7,^"?%D^M>+?%FFW$L4C:+J$4<6Q-NR*2VAE4'KDY9N<Y]
M@,9/(/4Z:BBB@ HHHH \3O?V?? _[4W@7QSX2^(?A;2/%_AJ;Q9+//I6JVJS
M6TDD0A:-F7)#X.&&[V&.*Z'X%_L;?"K]F;X6ZKX(\!?#[PIX6\(:[--<:EH]
MCI\:6>H/+$L,IFC(*R;XD1#NSE5 Z5B+\7[;X*^"O&VNW5M?:I:P^*KB!8K9
MTD=6=8P .F!YG!#$D;N.-JUJ^ ?VG(_B3\'-9\7Z/X7US5!I%P\"Z9;36D=U
M?%%C9C&]S-#  /,/,DJ#"'OQ1>W]?U_6X:?U_7]==2"S_88^$5E:Z/"O@#P^
MR:!=->6'FPF1H)&,3$[F)+ F&$[6)7,2<?*,;GB+]E_X?>+=$N-.U'PEHUU9
M744T$D3P<%)KL7LB@CE0;E5EXQAU!&,"O,?AE_P4<T3XC:QX2LI? WCGP_)X
MOT*3Q5 ^J2:5$EIHX&Y;V3%Z6=2,9C@661,@LBHR.W>_!K]IVR^+OPWNO%TO
MAKQ5X6\.I8C5[.]U>"#9JE@R-(EU"+>65@IC7=Y<@24!E^3D4;!;2Q;\7?LH
M?#7Q]HVF:=K?@CPWJEAHU_<ZE96]S9))';SW,CRW!"D8VRN[,Z'Y6)&0<#'7
M^%_!NE^"K>[BTJQ@L8[^\FU"Y$2X\ZXF<O+(WJS,237CA_X*+?# 7?VG^V_^
M*;.BC5TUKR)?*E<WK67V18MGG-<^:N/*";SD84YK>T;]N;X2>(?&NB^'K+QU
MHMSJOB"TCOK")&<I+#(DDD;&3;Y:%UAFVJ[!B8I !E2 7ZAN>L45QWP7_: \
M'?M#^'[K5/!FNVVNV-G<?9II(D=/+?8L@^5U5MK(Z,K8VLK J2#FNQH XK]H
MR3R_@1XM(8H?[+G (?9DE2 ,[EX/3 .3G #9VF+X=X_X7!\0<%3^_L,@,"5_
MT1.".Q]CV(/<5+^T=)Y7P&\6G('_ !*YQRX3.5(QDLHYZ=3_ +K_ '3^77_!
M57_@NG\1/^";_P#P4!\6> _"O@[P1K6G76DZ/JCW>K-<&??-&\90+$Z# $>>
M3NQVY6E*2BKMFU"C.K+DAN?KU17X!3?\':OQI\AY#\./AE&-K?*)+T>2PW)L
M?YV^82/'GG!P0.0:DA_X.U?C*UVWF?#KX8^3D%EC:]5XT)QN^:7((.\_=8$(
M"!SSE[>&Z_K^OZZG5_9E>]K'[\T5^!$7_!V1\:A;YD^'?PQQ'&JSNCWK>6?*
MWF0YD&WG/4$$;3TW$2I_P=A?&:27RC\//AAO9MF$N;S.\D2*H)/&4) ^5B0H
M8#)*A/$077^OZ_K<I95B'LOQ_K^OD?OE17X&-_P=C?&=@6'PY^&H#H/FQJ&U
M%7.YPN[.XLP7!)'R<9/#*O\ P=B?&ERI7X;_  T9904PKW[[9 YW)N!^7'W<
ME3R!\O0.?68=!/*L0E>Q^^5%?@;;_P#!V#\:9HD/_"N_AED(I<-->HZ<8W,I
M;().6(XP5"\YW,+_ ,'8OQFEW;?AU\-3+M 9";T!0H!<XW_+)\PRK-@* PR"
M:/K-/N5_9&)Z(_?*BOP9M?\ @ZR^,MV7'_"N?APL;.T>\3WFZ/+8'.2 P+>7
M@@\H2>A0[>E_\'0GQKU*X5!\-OAX.OF$_;%" . 3_K3T#Q[B-P')/ P4L5!N
MW4IY-B4KM+[S]RZ*_$V;_@YS^*]M;L__  K[X>R>6I9\/>?,%#[@BK(<LN$!
MRVTEU4-DYHE_X.@/BE#*R'X;> 25)!*7%RRG'H3("1^ ^E:.IV39PK#R;MH?
ME4[A)E,CE@#@2;B%9R<L^]A\KL0_SEF&Z,ALIYF+D4:SVRY2#9Y;#(5%5T*L
MVW!X0;M^1D!3'U*QMY56-_(DWH^ BHH>)<MA2=CKC.1NV* "ZY5 & 6(M<MI
M!!'\PDC$>"ZI(P:)5!E;:1G&T0,$.3E1'ACY0W>?3UE_7]7/?J/L6))%M)F8
ML/DRQ$AP#B0'<V[D;F15;<1_K9MV")2L<:_80BX5Q L:N)4.TJD:@$AN@_T,
MLPZ_/@@-$=LL3&VD&Y$WP2>7(L385&1F#8*_,H!B&-H)&Z';DQ1!Z\4_V6%9
M=Y7[.B2MD#/RD2<QKP,K$2-IX"JH.(=QJ7W?Y?Y=/74YHKL6;-6MX 44"2!(
MU#C:SKB)%3(Z$?(X&<!MS#(2239+"@BS)\VR(9!'+?*N< D9+!8(&'&2(\X!
M=PD5M&UI+Y7,3PDJK%5(!1P@(.,':T:X&.EH,C!^:S:Q 1QJD6%*!0BG&&8K
M&B$D?+RMO&&YP#GYOWFQ[Z_=_7]/[A6UU_KM_P  29&20J"!,!L5C)D*2)AN
M!PW&3)]%21OG+,@2>0;&9 R)NP$9_F5!NE5>!_"LFTGD!E?KM(F</W]W"B".
M5OW:(&5AYF05P0V=HS.Y(YVYD&&$3"6$L9HD*L3.ZHP9^NXQ@J7SG#;Q;[@=
MP&YLLX$V;>]M[$Z??_77_,+:$+$Z?+&!A1MP /GP&()Z O*Q7)Z$;L%GJXTI
MMHY)D41/ 2X3.X (JD'& Q'SG.<%UN0,AB%C@'RJH@;;G$D/[OS60%72,X.2
M<1JCE&YW*HY=E)E<+)#LV*D<NSRXU^; ^:( %CEF&$C;G.)R6^\J*;*[U_KM
M_7JA3=]_Z_K_ "ZD)LA#$ZX#F/%NCL?,9>D88D'YB52'ID,R.HY://?_ ++"
M+_PU%\-%V-$LOBW3 5P' )N[>,M\O#L/,*G'WMJ?-E8U?A')NH6D_=GS<-\S
M[04\MYMV_GY2'92QS@,A))B??WW[*<#2_M4?#G (<^+; DO&N5_TG.2C' ^6
M56.X8# *3A<#:*:=KW_K_/U[$UM(M7V_K;^NJ/ZIJ\A_;YT3Q?XE_8S^(^G^
M ]%M?$?BV^T6:#3M,N+6VNH[YFP&C\JYDC@<E"^!(X7.,YZ'UZO!?^"FGQ=N
M?@E^Q1XUUVPF\>6>I);QP6-YX/T*76M3L;EY%$4HM8V1GB#[?,^=?D+#<,YK
MH/(WT9R__!)G]G__ (9G_9SU#PO#X0\8^"+"'5VFMM.\0Z?H-E*0UO &DC31
MRT15F4Y:4^82#PB@(OR3X"\8>(=!_P""G=GX<\<>*/B)?W&K^-[/6KVQC^(^
M_P ,Z!JLFG@II06/2T#,L9C>.T:[C,J!20V3&_U7_P $J[>^NOA7XW^UZU\6
M/$%CJ&O?:8=4\;Z7<:5<ZA+)9V_VR>T2:1YDMGNA.R)N5(L[(U"(K/\ #_PE
M;2-8_P""EVA77AF_^+7BKPM)\1=-:*Q\3)XLE_M>5=+D7_A();N[5+-1;&,V
MR6\D1SY2%7!\H@V#;^O\CZE_X+J'Q->? 7P[IL%EX+M/"NJZ[:6+^*=9UV73
M3X/U&8R0PWLV;2>W^Q['DBD>4@J9DVC)#+ZA_P $A=:C\1_L%>%+]8CYMU>Z
MH]S=G47U'^UIQJ%PLMZ+AH(!(L[AI%*1B/:ZA>!3_P#@K+\8O&7P)_8UU?Q#
MX,NM-L)[>\MTU.[NX+2Y>WLF+;S##=ND$LC.(D*MN.R20HK.%%=C^P)\9=9_
M:"_96\.>,=:BT^%];>ZFLDM6A^2S%S*ENLJ0O)%',L2JKQK(^QE()#!E!;J%
MNIUOQW_:!\/_ +.7A'^WO$R:T-)BW275SI^DW-^MA @S)<3^2C>7"B\L[=!T
MS7:6]PEW;I+$Z212*'1T.5=3R"#W%>1_MC? WQG^T)X%T[P]X8\3Z#X?TI[T
M3>(+75-*GO8_$%HJG%@S0W$#Q1.Y5I"K$NL?E$;)7KTJ\\.#Q!X8BL=0,T#&
M./S?[.NYK/:ZXR$>-E<+D=,].#0!A_ U#'X-OQCC_A(=:*G>6)SJET3UZ<D\
M>@'T'8UQ'[/UA#IG@.\@A\[;%K^LJ6E=Y'<_VE<\EW)9SC R2>F,\5V]'0.@
M4444 >?_ +5#;/V>/%K9P8[!G'..001SD>G8Y].:_-F.V6"=XXT\KRE9-FU!
M)#&#@;0$^Z?)!^=2,@D@'Y1^DW[5'/[._BX;M@.GN"=VW@D9Y^G_ .H]*_-=
M(UDMHOEB6VEV.BA%\E1E=N!MX9E)*XX!&X 8&X >)'"-+F?8SEF969C*OEY+
M,N _&7^4#(R-QY(KPC]J]%A\9Z?'^^ ^Q#]UL1F==\P((QE\N5C]&\S:0V0I
M]VDMWR%,96;9(B;49W4EOE"LZ\=1A3_<..$%>#?M<1?:/&%DORGSM.P(U(XW
M;U+!002?W@0 'YC(5 R<IX?$'^XO7M^:_I'Z[X&?\E=12_EJ?^DL\IBMH'U6
MRO'2&:ZM-BPW,HR8O,V/*%?YF"2LL.\\EA<J<-\_FK9@)! @RPCC1MIPK *+
M:+[PSM#)$,G.U79.<#<9)FDN7F89F+O*PV(9E=VB)XZ;OEF/('SI FT8>/"K
M-Y<T4V7:.*;>"W[P+@^:K @_,Q4!\C[QA!'%R&/YVF]+?=]_3M]U]=GH_P"X
MDDI,\DU4[=6O%(9Q(SADA4?O4Q$,!<88%2P!"OA"0K%L**]T7CMVF!WR 38G
M3Y"9  OR[5;&#&@ W$GD8?R\5-J48?4KF*/ CGD,(P%E 7]VI)7@%5QP7# E
M@Q.W*B![A"!-N5A&LCG*EC#SYG+DX)P%)!91TR A6N3R[?U^?3O:Y]I2UA'Y
M;?U_7H?=W_!O=S^W=KVT%PGA"_4D(F0#?VQ7+?,<#H I4 N>.2*_:6OQ9_X-
MYS_QG)KH_?3B/P;<H<R*_E/]LMP78KGLH3<=N[(R789'[35^D<+?[C\V?P']
M(VW^N,[?\^X?J%%%%?1GX0%%%% !1110 4444 %%%% !7RU^S]_P4%^'WQ0_
MX*+?%SX(:%%XIG\:^%H;?4M<,^C20V>GE(XX0IG; (=# \>,AA(Q&,-7%?\
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MNFO]?UM_DC[.&J2CV_R_KT];GW3_ ,&\VZ;]N'5VW^:!X-O")!EU(^U6(;!
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MO;_ABZCB.9I'VCYV8#=L5C@2%CDEB J+N;)^^[C+!F%@CRGE!\P"+ ;<A&W
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ML"#\S\@@@G<<D'IT'S#7T]_P6GF\[_@K+^T*0XD4>.=252)3*=HF( +;FRP
M )W'D'ITKYAH!;'N?_!,[/\ PW]\(\ EAXEM2 $W9(;ZC _VLY7J.17]$<TH
M=V1IHH]ZB,@R1DHI.U)%SR&/'!)4$$#@-7\[?_!,\C_AOSX2Y"$'Q):CYU++
MRV.@!/Y#([$=1_1,TKK,8S*\7SEB'9B6)D<#+,^!G#;ASM$IP0 N3S'RWTL,
M,@,3'Y8X4+/C/R1XVOYK MD;6!((!^ZK>I7PG]K1"?&-@T4://\ 8^-J#YCM
MN),8Z??1"!QRJG@KE?=C(2ORKNF&<#=N=W.V38N\,"I.,Y(&2P]2OA'[78QX
MNL]A.^+3PZ-S\NU)V5\YW* _EG/&.HPVVO#XBO\ 4I+T_-+^OPZ'Z_X'*_%M
M!?W:G_I+^_\ KY^6JR"XQ$!(@D C0DYE0O,@Z $9Q$ <<>9$<%CM>.(*JQ^9
M(B#;\TN1E1\RL<9P )#NY[*1G;"0[[P*(YU!V1JC[49 ?*56N %"\+P'E^7A
M2+;:=H<HL@=HM1/&R1947;YN64^:A?EL$]74EOX;E6;!:=F_.D^WR_+[_/7\
MK?W!KRKO_7?_ (?:YY!JZK/J=[M"Q+*\J'R@-PW>9(P" JV%+;MI+-@@@ YE
MJ.1O-O99?+.XDO,$!9F#21K\JC:[;EA)!/)X^^ &$NJ*9=2G7YV=B\2I\R%U
M7_:SGEI V>1$,$@.&(AN%\[[3'MW;M[;/*W$Y:8YVMD*>!N9D.X#&7!+UR6U
M5OZ^76W_  UT?:K57\E_7]=/,^Z/^#>@B7]NK7)&E@DF/@Z[5GPKEC]MM]P5
ME)QRHR3@D  EL#'[4U^+?_!O2YNOVZ-=8%G\OP;?,6$N_8'U"VZ\,VUL9&YE
M V# SFOVDK]*X6=\"O5G\!_2,=^,)?\ 7NG^H4445]$?@Y^-'_!Z^2O_  3V
M^&'7:?B!&OW01G^S[PCOQP#R 3VR 3G^9JOZ9_\ @]:./^"?/PT^>4?\5V@V
MJ-RL/L-U]X;A@=/FVDYP,C<<_P S% !7[N_\$+&\K_@FWX7?"A!JVI;RXVC_
M (^AN;.TYPI'MQCU!_"*OW;_ ."%J_\ &M[PSA?WAU/4^8X55POVDG=D@[\;
M6YY  QC@@GD%U9W_ *U/KE3Y:HK[X\-&-\S[%8]01@!"2R*"% R'&XXV@Y?Q
M%B:3P%K&Y969[=V+A,A_W88D DE5P>?FR K$9^6M9-RRMMPS@MY@612NX  (
MQR"-R@\+R2&/\?.-\18XXO VL@^7@6C%FD1]SL$QO+\E^>^2#P#G!48XG6C/
MM9_U]UCTLB_Y&>'OUJ4_/[:^7^:L?) <O8R,"_,3N5,IC;9((Y6)8D[<O( 6
M/W25)^6(DRW*',J9D\DK*"R1^7N5G9I-J$\'YI#LY(+1QGD/LCMT)LX_OQ@*
MH60GRRG[A!@=E(^5^>%,(/W(*>5!D^[&H+%<,3'M)C!(4'E>(".A"E6&"8DC
M'Y)LOZM_7_#=D?Z7OXKO^OZZ>7WG+?%4^;;V (A<-=-DC:40&3>,DC!#*J[.
M?XHR-@_>R<3:)YLEMRNZ0"2.=5^<,8GR^78AGV1H?,&XX(X[MV?Q5*^19;R0
M"267>4QG:C+C<,-R<'+;2_&XQAFXSS") V^3<RLK!2NXE?/+I\S<LK,,KN8
MC=MC&".:M:[7]?\ #_\ #>OTV6Z8=?/^G_F1N1'#)(Y:U0Y68QS*CQ?NGE/S
M':5*&48+_,/[IZU_1W^P;')%^Q9\*UE"K*/"]AO"Q^6 ?(3.%P-OTP,>E?SB
M7?\ H>GNZA/+CA(39""C@,'5%8!596$D:JJE?OMM9F&3_1Y^P?;"S_8O^%T0
MW8C\,V*@,,%?W*\?=7IT^Z/I7UO"7^\3]/U1_-OTHO\ D4X+_KY+_P!)_JQZ
MS1117WI_%1\2_P#!1CP-XO\ B3^Q'\3--\":=XAUO7QXV66W@T61GO$59(3(
M4\MT<!?FRH<'&>0,8I?\$E?V>/%$'[!OC?PC\6/#WBFSN=5\47TOV/5I[FVN
M[JW\BU\N1)$9)55GC)'EE,$$ #%?2WA3Q-?_  YUSQ5;77A7Q)=_;-:FO8;B
MQMDEAN(GC0J03)P?E"D>N.G.-I?C1*3_ ,B;XW'W>MA'QD<_\M/X>A_3->>\
M%#ZW]:N[VM;I_P /^?:Y]G3XQJQX9EPS[*+A*I[3GO[Z>BMO:VGKJ]MCXA\,
M? KQK\&?#WP*NO#.@^+=4\:3>'8CJ'AW5YM5>VL]2FA;SM8EOVE>**XC=8?-
M@NT=&38B")CS[!\ FU'X5?L@>,M6\.^$OBP/B58^&DGUFVUB*X>\U?6EMY&E
MFM?M9ECGE\TNW[G?$Y,:J&X4>_Q_&:1RN?!WC9,C)SIZ?+\V,'$GIS]/?BH5
M^.$I3GP1X[5S%Y@0Z?'G//R9$NW=P.^/G'/#;?0/C'YGR9\-_B9^T_XB\,Z5
M?ZA-XMCGT!YI9+5O"UM;_P#"4JNOPPHESYUK&\*G3VE8>2D#X"R?PD/TG[+E
MG\7O'OQH\<ZIXPE\=6&HW/@MM)WWFD6^GVNE:HM]=_N=/E$8CN(D4H\<["3>
MK@LY^Z/I5_C0R2;?^$0\;$X8C&G+@XSWWXYP,9_O#T;#5^-,IQ_Q1GC<995Y
ML(^ >I_UO0=^_H#1:X,^'_!7P1^,NN?\(EX[O;OX@WFM> / &A7=Q/KHO(M=
MU?6(FU(W>G00P&.S9976VAEDFMW;RI/,+/N$E?1'_!.GPU\2?A9X;\4^"OB-
MH][;S:9>QZQIVIOK\^NP7JWP>6YA2ZFBC<^5>)<L(\?NH;BW3)VY/JO_  NZ
M;;_R)'CKH3C[!%Z]/];^-*?C9-G_ )$GQSU(S]@B].O^M[T7N%U??OV_K_/H
M2_M'2>5\!O%IR!_Q*YQRX3.5(QDLHYZ8.<YQM?[I_#/_ (+]8/\ P5$\3EGE
MQ'H&B$%2/W)$<Y+CECD+N&T 9#ME6&2?VH^*?C[4?'WPVUK1;#P7XS2^U6T>
MUMS-:Q11AW0@;W\X!5!P"<\;LX(!K\5_^"_H;_AY_P"+-F4E7P[HDL8,7RED
MBN"'(!)?G:H.UL-LPN5W5E6M*%OZ_K^NQOAOCW/B=X)!;QEH< QJBEAN4-Y;
M,@#%L!7;!;+;@1RS;RZ2 G[2"OS$.LJ,X">CAL_+R\VP+C;N+L0NW=3=4MDT
MQKE52%0B.H$FQ^_"-DE<[ Q;<<D;RY5%.Y;E3:7,Z@OYB-(5,@/F A0D#$E3
M\[[TY.[<9),J3\L>;=]?Z_K;NFK;'5L]/ZZ^7E9DEO$C2PA5?RG:..,CG$;E
MR5RW4AD*G(^;)\P;6)-:[_TC2T4_ZVX53A4ZL[& \\D9.S'7:,!=ZCRVM,GE
MR?=RC2)$H9?D)49(!RW*D$=_+57QY8#2-1U8J;>)&V8D64LQ&=REGR"I;8PW
M,K8YR4)W,<NN>F[Z:?U^OHC>*NVE_5_^&'RN_P#9?GI(RCS4D&Q3MB8[IN5Z
M?*TBNH&X C8"Q^5H#%A"D2^7F'R@L3KD!P(PB\_,58QK_%PD6<B12M[4[;S(
M&3R<MMV.FUG)9R22#@,V5+(696)#84%R\34U)N(SMV'S%9B^_+.6,>>!N)XF
M"C;DL)#AGSEY6^J_K3_AO7S.M/>VW3\_Z\MRS#>9N2P^?]XS1A,H"7?_ &L$
M*RM$V,X:1DY5U+---=Q:7(JOF26-' A7+,BN$)0J<9)"JN  NYUW*['%5])D
M":G&S!0599-ROC:V40?=R!G>N3]T^;+@E0WFQ:?IRZC,R.G+QL,[2X<_O5^9
M,[OE\Y0RCYLL1A<L#T4:::4ON_']3BQ,N5I[*W3^K_U\C?L]16XM$N58FWSU
MB ?:^"3MPW]UR"$WC:!M8X)J![LV\+RV310Y5V:,R)*DB%')3& WEJ48J<XR
M"H^3FM%DA*N\<F#,VS.Y?W+.@*%B&5F;D?Q;AYG<-OK)UHS6R>?%<NT,@>7*
MR"0-G<0P/.0%V$[\#"JH)+L"ZT'!W[_U_6A6&G&I&R7_  ?Z^_?R-RTU2+56
MPV;>[1\8W#<K@M]TX8-@;SST!!PH:MJSBD2TB"_*H0 #.,#'IM'\J\PO;[8W
MFB,*8VP\7/WDP,8SNR"K_,.GDY_@4Q1KXTOH5"_9]:EVC'F)-"JO[@;. ?2L
M/K*2UO?R:3_KR[G5]4DK2BU;S?Y63_KN9%S%]J,WE[MTY?@D_?:.0+N*YRI5
ME?<Q8-N89(=W=7'VJ0R1\K*RNF/G8JV5W8^;<29(T<?-GYN)68EB,?;9ID'6
M20']Y]S<V%Q)G=C#9=MV>$)8R!@SJ2-1MR6.X3*CLTH,CA71 &?.2643.1ZC
M<WW5 DXU_7X&GE_7]?UZ11P;4V(/E:0;67]Y'C+-QDD?*Q^]G#JCX;.TM+I\
M($L,6=PE"JF6VB4;-G7.<%6C 498!MRA08E:&6074V2-CPEIXY-^]T):)XSN
MZ\&X8@DX+<[I,[6GT[*E=@="S;,(I)BB!B3:S-U5/,C.'VY$8#\8W;^7]?/7
M_@?(<F^6[Z_UN6RBS-V;>T:@2H4#$Q_QX.W;^\=6&<*#,O 6(HJ,T\>/,_>2
M1Y.^,RR%_,89(XW$F648P Y0<#[3L9(%/E *GDJ^QAA>8U.YFVJP& !'( O
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M;,ZJSY6583Y:@AB))4VXYR";-0!R6WX )9M[+)FF@3]V\QPI$9RTDK>6,@Y
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M7"R.74]3M:3 +@$';)+RW/S*2O\ Q\J&1_*V\_N\_O"3\H0'8?XB=JC:<9R
M(FSD1S"2==OFEG/DX*%G^ZT0\QLG&05P(TR#R@MR"?W6XZ_9?-M^?]?UH82L
M+>,L+3%TCD2/*E93@&,27*A!Q\O[N!E.>5$CG@^;YDRP-%($W-*\;N&95P96
MC;+,V P&95D8D;MNYA@[F#0PR,3N*[7:1>48*0R&,G@@#@Q,1NP!(P#=941U
MM&)V6,'=NV094#"#>Z#;N^Z&+*%!^Z H;.'1WN[OK_5_Z].I,K[/O]_Z^FPV
MVC8W(P9\L"1M0F5LID[1ECN(%S@Y.2ARS;W\_OOV3YBO[4GPW<,'5?%>FRA$
M8A"3> $J0"$7$R$,> GD'=A06\[<K-"KM\R2IYC%!LWAUD?Y0<X!#X4G&!+'
MGF!P>F^#OC6'X9?'3PEXDO;:XO(]!UFSU*YCMXD66007,4S(@8XW.1$RA@ #
M)&&_B:JO[PY+W6ENU_7]:']8U%?F^/\ @Y[^!LLP6/P+\8Y-SA%(T_2AOR$(
M(SJ'3$B<G'+J.N<._P"(G'X)%=R^!_BX\?F! RZ;8?-G:!@?;.I9XU ]7&[;
MM<+U<R/)<)+='Z/45^<#_P#!SA\%8HIF;P+\6E^SP?:)-VGV"@* S$\W>2-J
MG''S'( ^1RLD7_!S/\%I[V2V7P-\6A/'N^1[#3UZ$X)_TSCC#-_=#QCEG"DN
M@Y9=C]&Z*_..W_X.:_@K<@LO@3XO;5<(_P#Q++#?'\NXY7[9D<AE [E"."5#
M2W'_  <N_!FV;8W@?XK&7RA)L2RT]^K8'(O#@$9(/^P^<!&(:UT0I)Q^(_1>
MBOSDU?\ X.:?@KHKMYO@7XN%0VT,FFV##);:F<7?&<-G^Z%[[E#07'_!SS\$
MK0$R>!/B^H4D/G3; %=L2RL#F\&&VL3@X.$8G'&3K8<82DKQ1^D5%?FW+_P<
M^?!&VN/)F\"_%Z.4,(\'3+$C=N (XN\_=(8#&YAC"D,I,TG_  <W_!18%E7P
M-\6)(CD.ZV6F[(>A!9OMN -I#$YP%.X;@&*D6I:('"2W1^CU%?FZO_!SU\#R
MR@^!_B\,N%(&F6)8#'S?+]LSD%9!C'_+&0G&VF+_ ,'/WP0\L%O!'Q97Y59S
M_9]@1'DC>21=_=09)/HN<;2K%7#DEO8_26BOS;;_ (.>_@D@.? ?Q@4CS,JV
MEV.Y2N,*1]K^]C<Q']U&(W<90_\ !T#\#HU)?P+\84 *\_V9IY^4L%W?\?O3
M[Y!Z$(<'(8*<R'[*;V1^DM%?FTW_  =#_ E$#-X&^,BKALAM,TP-P3_T_P",
M820DDC 3_:7+D_X.@/@:YP/ 'QK)R%_Y!>E<$D*!_P A#U('UHYH]P4)/5(_
M2.BOS@C_ .#GKX&N1GP%\:%W#*YTS2OF.[: /^)AG.["X[%ESC<*9=?\'/\
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MD.LJ[@!A,G<V!N:-0%3#-M66XB-H(I1+YL#-M,I5OG+-P1M_VR,E&P24(!R
MQ*FXQ=^G^?7_ (/;L8J2E+RZ_P!>:[^I G^D(C%0B-*CLA/RJ5#@Y VE1O53
MDA&#*HY8")(+B F *_[M)5D5FD;: =V6+\ )E6EW^T2':@(42R$>46E5G^1W
MBR%)DCVQJWSXVGYI21@;4P/]6N4I\EN1.L;L5E=E0N5*DGS-X;)&3S&WS#!4
M('*E1Q+NWIU?X_UWW[#OU?\ 73[O0S+I2KR[XBS8=FC?Y-[,K.48<$%C.>_
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MK[0TZ/M<809S$$&&#90,(EY'J0Q782I!;RPS!Z+6:77^K?UW[[#CHM/7[O\
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MY9$)(QY@D4&5F XWY:4\@D-!M ?$E.$N\K)*X1I0,S%PNUGEPY).Y0 4D/\
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M]?U_6I,DU*R_KT,RY@>-'N  MS;[C(8\*'=6P[I\W9HQ@   W&#C!Q)::I'
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MS?O$D9LA6#/PI9H\-F!LQ)&P6+R@ZB#D;B%4-M"G. R3+A> %8*<L95NSO\
M?_73R^7D39WM_7]=.H7:L9Y'("F5'V98;ER'^4-G"J ,ECGY9"[-N1<3SRB1
MI-K<EI$AW*0KAE)3<!\V63IR"-\F 'BR8;J$-P<2AXV.Z0%C)'E1M.W((VRE
MV*<MY8*XW125,%:Z?9*DS^>^V5 0SN[3;73(('(FE'RX'S*05\]5"U_K^M;?
MFP;V?]?C_7Z7(9-]R'C+$,X*$_NVY(P21C;_ *]<],9EQC8GE-BB.V!5#%&:
M,X ((#!?X5QAMA3Y1M(W*!MVP[*UM?>9'EG#[_WC.\BXD+$'<.,;3++(.@ W
M#CYF%691@$?>SG;DXW<D#ENF<#KC[Y)X67&J:M=;V_K_ (;TV(<;;H?;H;R+
M!C\WSU)51EA*[1.<9&"05EG/&"0NX<OD/@G>.YBFWD*)/,$C,$W9\R0DO@#[
MI9L] KSXP&3;# <MC=YFU@A#<;R"BD-TV].0<$?:),X*,$EM#NN89 [OEXL.
MS!&;'V1\GI@XC/.1AB@X(VQMM\NNW^?7\?\ AS%I$,$"VWDAMH3$?F\=$4*&
MRJ\[@D#C;Q@EEX.RH0\L$+>:,R1Q%I,G.YA$VX  \DO&ZGD9R2"!+'Y<MDNZ
M*WC);Y%B4!6*\C[%C&<;<E/PRO VR 1(8C'"[NRP*(R[QK\NP1N,X(Y"HEW\
MO..$*G#(U]->GZ?UZ+\3:.UE_7]?UY6X+F6!\!U=K=RAW!6R1(Y..%!!<*=R
M[<B.-MR<M!9#"'.%F,<:L4#LL.X(OFQ#<0%!.R-QD80.Z[,1GRZ"22/&&EXG
M.&=5;S &P.C?,6PP('#9 !^??BZ>PQ&^S#%25Z_*ZX9<<[CRRQ\Y)"GJQ8M/
M<6[>]_7]>FG0QE!.7NEF7;&1EX"K.FXNFP*JR* 6#<C)6Y=LMN$8D5\; !9T
MRZE$]N!YGFAHY -Y^?D85@!O+ 6Q#$Y90G*D;PU.>?SI&DCQA9-T:C_6$'!'
M//>*(#.<%DQD)^]CC8)*IW-@%<LH')!/(!R/X8R!D\L,[@")'&]K_P!?\'7;
MHR'335I&]82QSZ L#JYA\M1N'>)82G"D&,_*.@/EG.X9#KYGU=X&^)/P;/P4
M_9QTSQ+XR6>V^'?B:ZU/QEX771[R:XU3[;?1*Y$O*-&MM%;D@EBPV[&_C/QW
M#+YD/R[4E"I\RMAE9<J<$@G#&:1OXFZEA)G:]R25;V8!E&6E*X)=ED59-H.-
MV0R<X )+2+(<93S*IO7F]?Z_X;IL8<C7I_7]?\ _43PS^TEX,^+/A77-?C^(
MOAG6=4^'_AW7Y9_%MSX/DM]/MM1UF_BM-,@@M=@DD2VM S1X#%5?=@HQQY-^
MT)^W#\-?'WP_\;R>!?&\7A#QAJ^H6]CJ>J7_ (6+W7C_ $Z#2[>U)C B*6HG
MF,\TL0 8%P2&;A/@V+YWB9W91<!&E.P$/$1"K$_P-CSY';(QF9CDA2#,EH=:
ML&D?'G2 >:8BH,F<_NR-XY9MX^49XCVDE0U'O6;7]?UUMOLKBY8MIO\ K\OZ
M2/T=O_\ @HI\'?&_Q ALM?O[6_\ !NA>,+1/"BMX<WPZ/I>GZ'-9V5S<1J,R
M)+J!A,L);)2W'R(L;*EKPE_P4E^"&BZI;1>,-?'CYI_"FD>%=4UB7PTUK]NN
MIM1FN]1OY[=(U5XX&ATP"%\^:JJC#]Y@_F,Q>$$,Q?<-VY'&"63&]2#C[KS8
M(XQ)Z(H1ZSK>LJL=H:(HJ;V&QF7C:.2HWR)@8.&)7&X1K$N:2Z_UV7GY_EUT
M]E=7E^']?UY'MG[7FJ:G9>%] L]6\;Z+XJU'7/[1\57<%AIL,5YI<MY-B-KB
M6,[I9)XHHI5C)7R#@'RV<K7T_P#$_P#;(^!UU\ K;PC:^)]+>*_\*^%_!*WF
ME:)=6NJZ;:6UVL^IF]NV(B:S:42[8(XF$CL"<C<K_G7>6$%IYSKY:(T&\R1A
M8B4\N0K@CY<A)<#&0,1<_NY"MNTN+FTOG=IYS]E5FFDC9F8B(JQ4;>%&1* "
MR!?-9?E/"N\N9*W]?U]WJ)05DUZ_U_5_/M^BG@3_ (**^ /&OQU^(GB;7_%M
MCX#0^-]+A\/O%X02\5_!T,MRT^FVT2PE4DG<[I'D!\P*Y .,5R?B7_@H7\.-
M!\*:YK>@OI]MXTG\,ZQ_9RR:")(K75=9\0^?/(JNHA!L-,AA\ML%09@$#G<#
M\'WL-[I B\VWMO+*3!8PNPDA5 ^90&X^8 A=I,:HJ("N5EA\J[V1L'V/L4X'
MSM^["_=..6*'@_\ +7C&4,<SYEIUT_K^K78X1@U9?UT_X='U[I?[:_@70_\
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MHYC0LZQSM)M!'S!%\L[U8>:,L-W! X<TDOB;5U"^?J&H#YERK29AZG.UO+Y
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MRPFR2X3_ %9SNVF0C)(*)US5SA.5N9_U_7](F%6$%RJ/]?U_6S/:%C^U2+A
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M[?U_77Y792="L0C;SG6%5B;!!V ,?, .0%)%NJ;A@&1E(V-N 86D##82TB\
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8LJJEO%V3_O./XV?];D22O[Z?RO\ H?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>a03.jpg
<TEXT>
begin 644 a03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" %  CH# 2(  A$! Q$!_\0
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M;?MO>%OV.&\):;K>D^*O$GB3QW>#3M"T'0K 2W^H3(H(8AMBC8Q(7:"-^TC
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M@V?TD'F3QQ.T7F2O 71&B/S.6921U[;N4,ORR,2&#;I1MDX(BD:8AV2#,I?
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M#_1_BOX>^-RBYMKB75+>UDT"\V."MQ;R$O+&LF]1CCY=I"Y./LG]GZ+QI:_
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M!Q&H5J(E,AB:( &16\M\<X/E1J,A^3O/.)#D*"/^6>UR?]?UW7Z^06=G\_\
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MD=OO>$G<7D#')9,OG_5N,D2.2&(,NW-:A\*W43-)FW=MQSY0,;,&.6<= ')
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M6+#F/#<D+G:-R@&3?C:7?2S_ *0T]+/^E_7S_ S5,<2%1Y>W$B,J2+M8(HR
M1(HVECR2>=\0=P5V5+)"SWA6;8'9O*D8C!XW,[8.PE58[_F)4H\BA<.IDTSX
M>OI'\QI2'9PS8?=M)9L[0V1M3<77?O&6^ZNQ (AX1NA$HQ: +@^6'/EDKR 1
MLR=Q.6))XBC')RX705[+^OZN9<CKN9IAY>Z/?*LLBQ;B09'!)V$,5WY++E8^
M%4'S0)X4$M\NYB9/-#,P5_,! 56Q\S.&*A\*"6C1R&QO^71MO#%W%,&C>.##
MR')=SSG<& 4CY6<!F7.YN=SG)%)%X3N5,?\ J5PT#$"7=C8JJ1S'ABI&Y21U
M48"$E@^FO]?TA[+7^OZ1DVK['@?;&TB%'=0@^\"VS:!LS@ABJ X(D9AYF[('
MC-NB_(OR(4#%  ?*=7&2^WG!50VX8=% \D[EK3M_"MU%;196+$4838&/(+&1
MQCK\S! 4\S! ^9G P47PM>Q(I41K+$&_>*X#,S*$+<*-QV!0/N8*X&%V@#M;
MY_U_7Y [6U[_ -+^OP*5Q;;_ #08?-VQO&5=';S,^=)CF,M\R\%>6&1N612"
MT:[)XT ,;;P6$B!9'/F1.REN2'D8.5!1\97A@'*5J?\ "'S)(NV.U40NABVN
M%^5,A,@1[?E"QD#!4'HNY1(1/"MX0N'C1@@0EG+<9((Z$LO\7S,3(SG=@*%I
M">IF_9_WJHT828RQ(D;(0"X7>(P0O W'=N50RA0QC!4O49N(Y;>9]VU9D9@?
M,P?+:4 !OF&6P)<G;EM@XG,8+:UOX3N0BMM@08C)B9@=ZAW=HVPF.K#!PP )
M"JA_>%5\*7L4<2B:+=#AED\Q]P8')Z[B-V.N>YW^;SN?6Z\BE\5UY&9<G$LD
MA !,MPQ9"$(;:%.'Z*P/FKGS/E+[?,3<$#BK07>65DDB5294BV2*-@4R*-N[
MY3\JIL(<D#;]YJT/^$4NR^Y6C!(#;GD;?D(BC.,DL I^9F<[MK<[%4'_  B=
MT&!06L9WEAB5OES("22%!;*LQZCYU#?>;<JOI?\ KN*^E_Z[_P##&9;RBT9)
M6BB@";)5$<D>U I ";U&THNUT50I8[%8!77<6FS:"W,*YWM!)&5 <9*$EON@
M Y5=IV"1MS#(E5!C3?PG=2+M_<A3&\0(R"/F Z@Y"M&B+C+#(4LK8-.NO"UW
M<+(PCLF:0O(5D_C9EY#Y#D@X$97<1L(V[2BBF@7]?);F?<92\E8MM\QI=CN0
MOF(NUT?(= R^8X<$$@;F&^,OY5%NX@N5+#R?+9-Z.H5F#*SRA@3N8E=Y(QR5
M9]@)5SHKX5N?,E(\K$GRGS&PS#)3)P.<QDL3]\LQ&Y0>$7PG>1QQX:U8H#P2
M0.P*'"XVOA6<*%7*#"Y8L%IM_7]?UY!IMY?U_7;[C+B#B**%PC./+"+(5;>=
MY*XR<.I5V^XNSY@H,/EDAI,8M)@IB(E4#<%RS,SED'\0PY#89E^>8$,.?+K4
ME\+74*L L4BOA6V.=Q(#(CG?D,?GWL9/,(,? <E=JS^%+MW_ .6# B10"[X5
M6RV"<AMI. W)+G:WRA=E/J'7^OG_ ,#3\"@)4-R6\Q=Y8OYBRJ9%+ 1CYM\A
M'78, N6EPNT!LPNX2(I((ML4<BK'(JK'&K##*%8A518D*GY=B,<'S6#UJS^&
M;VZ6XY4&6)B \I5<L^XIA<[<_-D\CYUR) @IQ\,70EE*;$B:0GR]Q&XF4 ,0
MI7A(T0@Y+<  H 586R!:)&7<;F:9"<;VDC+;L&0R1LX4M\O1E8LN!M!.Z+&)
M:6>2.XDG:26-1('WRR/@QH79'(^<E1D;F5B0JPA6"\"/2D\)W;QMGR)#@X62
M3.['(RVSG<Q);C&0K;6.[>K^&+T2G;+G#,R-Y[C/0 N>NYAC)4<!"JXWFEI8
M2M;^OZ_KJ9XF<7Y>43Q2,1,\7"R%F<H1@,IW%8RJG+' &QI$WBH[.7# Q[I
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M0NSW(='Q&@$?S8^7: I9=LN$(YWX*L)-,>%+E%7RU@"Q$>4C,HVB/=Y:_<8
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M0%>;YXL*=J[23N0X&X!-WS[3@$^6W TCX-N/+$/FP[-GE;UW<!@S.=I)_B.
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M@1)40;\[8&D&_*D?1%OH&I>2BRW$;<+O9II6;/SDGJ <,PZ!<@#[NU0M/7?
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MXHSY"A 5WIN(\K&\*K-P-@VA1M+85-@ZO3#]ITZWD,RS&2-6,D<N4?(!R",
M@]L"L-O!EU]EV!H-PCVAO,8<EP<X"C! [J5.<[/*R:U9;75S*VR]TY4R=H:Q
M=B!VR?-&?RINE"HVIV^:_P" %VMOZ_0TJ*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JMI%<)>R&65G3DJ JA
M!DG '\60 ,DG!+'&.@M44 %%%% !13)YA!'N/3('4#&2!W^M59=6WV@EMECN
M%E*K#B3'FDGKT^[CYLC.1D@>H%UU9=J);R)[EH1+&9E&6C##<HXZCKW'YU#I
M][-<, \:%0.94;*N=JG*CT.3W_A]ZI6VAR_\(^\<D<+WV&97D8N#(N!&^6W$
M?<0]\$#O4\W\NI/,GL;%0W]_%IMJTTS;(U(&<$DDD   <DDD  <DD 5@2I-X
MOU>>V^T3)IUH%239L/GRJYS\X!VX(Z##@J#\G!=UU8R:/?6\:WMVT4S;$$[O
M(T<C(ZH5(Y? ^\IR %#GG<YCVEU>*_K^OZ[)2NKI'06]P+E"RAP Q7YT*G(.
M.A X]^A[4^L7Q"DM@DDMO')<W]V%B@4%44-'OD3<05;9G((R>#TY;,;Z/J&D
MI+/!+;R;8BHMX8%@&/F.%))&1\N-V1D-T#_*O:VW_K^OZT+6IO45A)-%'I,.
MI+>;X[B2*2*629HT,4CKU5FQDJQXP.<8' %2VOBZ*\O_ "T$00A60O(8Y)4;
M #JK*,KN91G/4_3->T5[,%KL;%%10W:7 7;N.X$C*$8QC(/'!YZ'GKZ&I:T
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MZ=?;)=@LSOZ*X$67Q1(_Y"?@$' '_(,N^#GD_P#'QSQVXZ]>.06?Q1'/]H^
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MRY(!&,ANA. .-?P[\1KGS'EN_AZT\B+EFTJZD!9<;1S/]T9<^Q;IU)E>R^*
MER+[P V. QT^[!QQ_P!-CC.#Q].N.59O5E*&K;_K3^OR[G9W=J72T,*D1P2*
MWEH6CX^[V8# !R5((..F<4[3+'[!:/!&@@@1B(%4YV+^.0 #G ' 7:,#&*XR
M#2?B3:6XBBU#P#''$52*-=*NE41@'TN..P  P!W.*62Q^)S)(!J7@/N$)TR[
MP1[CS_;_ ,>_V?F/-#T>KW_K^O\ @HZ(6EWH]_<7%I''>BX&ZXC$NP^:JJ 1
MNSR0,<L!A4'')-H176IWRM(IMK2(Y5/,_>2L&X)QP%P.F3G?SM*X/'Q:)\2(
M"I34? D9C6555--NPASM()47&,E@2>"0,X/S&G#0_B+YP;^T/ P.[SMW]FW9
M(D.5/_+QR A'UVXP,@K#IZ[_ -?UT)LE>[_KR_K\&=;K<,NH1 VH!GLIPX66
M/:LC;>@8C@?-RR@XY Y' ^M3S(R0V-RLVU<&9=L:L1G!()SC*YVY&6P#\K[>
M271_B."LGV_P'YZ)(JLVF73%-QR%#&?."0F>GW.G(VO-G\3BH_XF'@,$]?\
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MWA7Q_P"$/%?AOP/I/B2SO?%^K:)'I-UX<MHX_.CAMX634(WDC$D22B(([-G
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M:]X;E\7:QX-N8]'_ &=X/@Y]LTR&2:^L=1&H7MQ+?6S2Q)MB,=RF#E7+IR
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M-9\(^(AIJNCZA>WES!.DD>8QO4%9"S,5);)[X/,?M)?\$.?$?Q3_ &M/B_\
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M_P"O>3_T$U@? H%?@CX.!!!&AV604V$?N$_A'3Z=J .KHHHH **** "BBB@
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M@ HHHH I^(/^0#>_]>\G_H)K ^!1S\$?!W '_$CLN 00/W"=Q@?EQ6_X@_Y
M-[_U[R?^@FL#X%,&^"/@XKC:=#LB,#C'D)[#^0^@H ZNBBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HK\4KC_ (.<_BI.Q%K\/_AT6.0$+W\FU\L FX,
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M,-YI<DT;?-M!,C'=$OR(N3N7GYGVCJ7+=51<LS3-8=6'E$P28#I)MY4J%VY
M!+8*[3T.9&+$#!JX-QM_7]?GU],:J]M'W-_Z_K[M;'I&E/!-I@3,3Q)$8V#D
M8";=P4J2J@90Y"E5*J/EV8V:.6DFD3<KLI9V6,'<'/F9;(\QQGRPHX& 6P2?
ME3EM"UOS$0PX7"#R4.0L94%(X^YVC"*RKELS!3AR1)M27 GB5@I,:.9( V9
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MQ*IYW&2&W!@H?<02QR^W"B+=\K_K6KV]G^/_  #^C/\ B7":_P"8]?\ @O\
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M^7>D]@>Q^47Q/^-?[6UM_P ',NC^&=+NOC,W[.LVIV<5S%#H4Y\-QP_V6K2
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MW$EW< 8!2-(CM4D;Y'B7G=B@#V^3X=^'Y?%%AKC:%H[:UI=LUG9:@;*,W5G
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MV6X?S&G5V+ EF8NJE@S9965!\VYOWAPWRJM:VF_!5M,"F21,PN2C2;?+B*L
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MZCR/6.W]>?\ F<M_P2CT.32?^"GOP$=TV1IXXTMO+B*.A+.R[OEX^;<&Y!R
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M@!,?\47X8XQUTV(]-O\ L_[(_7U.>THH%<XM?V<? "8_XHOPQQCKIL1Z;?\
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M<[E4^8$"D+N.T9P>&5 5*]1T+C=R]Y>O;7BC*>6YWH&D58_+V["H.S.TN4&
M",;26&X"HJ8&,'9O^ON.[#XIUOA_K^OZ9_3MK'_!Q;^R7?Z9<VP\?W[F>&1
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M)>)W9MAR Q!#\L .=@!!*@",+VLI2=MOZ_KT_'14:45HMOZ_K9=3V3X)SM=
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MJK;PI&!+*\A8K&%VJS.TC%3&""W"D[B5-S]HO]D'QC^S[JEM:^-/#MYX;?4
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M/ 7@BX^S:YXADB6WL=/=V$/D-)N\MF,A5,@,1YJ<,I+'T(8I27+46O\ 6_\
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M7S4)C(7)#L"69'1R,9)(\LKCYVZ'))KNPN):5I?Y7_X?]/OX,7@XSESP6O\
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M'>$[G4?% M[W4?"7A'P;J>F#PL4'A]8]32^UVY=E4H[M_JT5,GR=P&[G&O\
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MG?RZRMM$X;$*F-LX_<(2%8,>FX# <\'(#9SSN9EYKP4R"/R,F0C"MSN(V88
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M3TKBOI;O_7]?H+F=[M?U_P /_7?^,[[;:R)'EHY(%6)Q [A_EW,2G7.7B=R
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MP+?*3)^]#79H8MCL;R#*,2Q\PDH6\Z/=A=I)R64X"R%@06P,5_8N_P#P3^^
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MV8G_ ()^? 4ON_X4C\(MP?S ?^$.T[(?&W=_J>N!C/I34_X)[_ .-$5?@?\
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MS*,A6)#-D%-A )\Q.!R2_)?^+^I#_A@_X'Y_Y(U\*>22<^$K#J>O_++O2_\
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M@SLN0 6((+C@D8##Y<M&_P#9#)^P-\"YI=[_  8^%#MN5_F\)6! 8'<& \K
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M DB)421'L5(\E"I(4LP1L*I#(W]EY_X)X?L_MG/P,^#IW9S_ ,49IO.=V?\
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M?]OYL^_\307*'>T!W\,)6'RH[)&R@;=VWC:Q8+RA! &<?U$-^PK\$F'/P?\
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?,QRS'P3II)/J?W-:1G9W:O\ -^7:QE.G"II-:'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>d01.jpg
<TEXT>
begin 644 d01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" "8 ?0# 2(  A$! Q$!_\0
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M'^)OQK\1ZAH'P!=OAKX)C=X(]?N+**?7]7C^[YB+*'BLT89*C:TP!4[HFRH
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M:\>[N[B)-3NHH@\CDLVU$51DDX4<U]ET$A1110 4444 %%%% !1110 4444
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M\#:5XF\,:OIVO^'M<MDO-/U&PG6>VO(7&5='4D,"/2MFOP#_ .#7?_@I;?\
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M1DN%C5P,$PRX)YK]DJKZ7I=MH>F6]E96\%G9V<2P0001B.*"-0%5%48"J
M!P *L4$GXS?\';'[9][X=\$^ _@+H]XUO'XI)\3^)5BDPT]I;R;+2V< _P"K
M>X#RD$<M:QXXW"OPTK[T_P"#E_QK=^+/^"P'C>SN&S#X9T/1=*M5_NQM:"[/
MXE[I_P!*^"Z"T?0__!/O_@EU\7/^"EOBO4K+X<Z58Q:1H95-5U_5YVMM,L)&
M&5BWJK-)*00WEHI(4@MM!&?TI_X)^_\ !MS\:?V-OV\?A=\2-;\4_#G7_#GA
M35)+S4%TVYNUND4V\L:[$EA4-\SK_$.,U]K_ /!NI\,]+^''_!(3X42Z=;I%
M<>)XKS7M2E &ZZNI[N;+L>^U$CC'HL2CM7V[03<X3]J'X\Z9^RY^S?X[^(^L
M;3IO@?0;S6YD+A?/$$+2")2?XG*A%'<L!WK^/;XL?%;7OCQ\4_$?CCQ5=O?>
M)?%^HS:MJ<[MN+S2MDJ#_=0;44=%1%4   5_2I_P<I^*Y_#/_!'_ .(\,!V_
MVS>Z1ITIYSY;ZE;,PX/<)@^H)'>OYBZ!HO>%_"^J>.?%&F:'H>FWVLZWK5W%
M8:?I]E"9KF^N)6"1Q1H.69F( %?I5X$_X-0_VC_%7@J'4M4\1?"_PSJ4R;SI
M%WJ%S<3PG&0KR0PM%N[?*S#W-<I_P; ?#"Q^(7_!573=0O;=+@^#_#&I:S:A
MP"(IR8;59,'N%N7Q]:_I7H!L^=_^"4/[+7B/]BK_ ()]_#GX8>+GTR7Q'X5M
M[N*]?3IFFMF:6]N)P4=E4D;95ZJ.<\5]$444$A1110 4444 %%%% !1110 4
M5B>(?B7X<\(W7D:KX@T33)N#Y=W?10MSTX9@:M>'_%^D^+86DTK4].U-$QN:
MTN4F"YZ9*DT :-%%% '\@/\ P4/_ &7O$?[&W[:?Q!\">)[.YM+B#6+K4-,G
MFC94U73YYY)+>ZA8_P"L1E.TLN<.DB'#(P'C^G:==ZWJMII^GV=YJ>IZC.EK
M96-G UQ=7T[L%CABB0%I)'8A5102Q( &37]BG[27['?PM_;"\-0:3\3O ?AK
MQM96K%K8:G9K+):DXR8I.'CS@9V,,X%<=^S9_P $N_V?/V0O%7]N_#GX3^$?
M#6NA2B:E';&XO(@>"$FF9W3(X.TC@D4%7(?^"5_[,NL?L=?\$]_A7\.O$6U?
M$/A[14_M2))1*MO=3.\\L09<JP1Y63()!VY!(KZ!HHH)"BBB@ HK+O\ QQHN
MEW)AN=7TNWE4X*2W4:,#]"<U>L=0@U.W$MM-%<1'H\3AU/XBE=,N5*<5S23L
M34444R HHHH **** "BBB@ HHHH **QO$?Q%\/\ @Z<1ZOKNCZ5(PW*EY>QP
M,1ZX9A5[1M>L?$=@MUI]Y:W]LQPLUO,LL9/LRDB@"W1110 4444 %%%% !11
M10 5^$?_  >$_P#);?@'_P!@37/_ $?85^[E?A'_ ,'A/_);?@'_ -@37/\
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MH":QA=OV@/CWN9%)_P"+DZWUQ_U]5_6_^T9_R;WX[_[%W4/_ $FDK^,?2O\
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M?X$O+6V[;.(DA65LL Q[EN2:V?!GQ!\0_#?4UO?#GB#7?#UXARLVF:A-:/\
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MZ;;QVMNF<[(T4*H_("@)'X@?\'B__)1?V;O^P9XJ_P#1NB5^,]?LQ_P>+_\
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M8Z5I5C9Z9I>F6\=I9V=I"L-O:0QJ$CBCC4!415  4     5<H(/PS_X/%_\
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M8PQF!8*7QG'.*_5?X1ZU=>)/A3X8U&]E,][?Z3:W-Q(5"^9(\*,S8  &23T
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M7Q#\4W5@EEHOA"'^TKN*UA\MS';^>]LEO)O,C+C*K')(S"'SW6_^"[?[=_\
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M -A3X>_#7PA^QC\1O$FE:1I_VA]=M!=+%KT\[M-)=KLLF!5R_P IW-\H49(
MH ])\:_\%A?V]O\ @C+\5_"+?M?>$/"_Q ^%7BFZ-K)K6B10)/$Q5F9(+BWV
MH)D!W^5/#^]2-@CKS(O[@?##XE:'\9OAMH'B_P ,ZA#JWASQ1IUOJVEWL6=E
MW:SQK+%(,@$!D93@@'GFOYZ?^"K'_!:KXI_\%.OV'/%OP?N_V,?B=X=NM=FL
M;K3]9>UO;PZ5/;7D,YD6/[$I)>%)H<A@0)CU&0?T@_X-:8/&NA_\$@?"7A_Q
MQH.M^'K[PQK>JZ?8VVK6<UK<M:&Y-PK%)0&V[YY5'&,( .E 'SC_ ,&RO_!:
MCX]?\%.OVEOB'X8^+6MZ'JND^'/"\>IV26.C0V3K.;J.(LS1@9&UCQTZ5^SM
MTYCMI&'4*2/RK^;/_@R0_P"3V/C#_P!B1%_Z7PU_27>?\><O^X?Y4 ?CU_P;
M*_\ !9#XZ?\ !3KXX_%?0_BWK6B:II_A+1K2[T]+#1X;$QRR7$B,24&6!4#@
M^E?!G_!SU?\ [8MREBGQ\M?"L/PC7QQJ7_"!/IPL_M3Q@2>3YOE,9/\ CVVY
MW@<YSS7IO_!DC_R<_P#'W_L7M/\ _2N6O>/^#W;_ )-(^"G_ &-]U_Z1&@#'
M_P"":.M?\%34^#G[/<>D:=\/C\"_['\-K92'^R_MA\-^3;!&;<_F>9]CP3QO
MSGC=7TQ_P<W_ /!3WXM_\$P?@/\ #'7_ (2:KI6EZCXGU^YT^_:^TR*^62)+
M;>H D!"G=SD5]<?\$G?^467[-/\ V2KPO_Z:+6OS#_X/>/\ DU'X(_\ 8V7G
M_I'0!^LW["GQ6UKX[?L5_";QKXCFAN/$'BWPAI>L:E+#"(8Y+B>TCED94'"@
MLQP!TK\N?V[?^#E;X@_%+]J2_P#V??V'_ATGQ2\;VEU+IUWXHEMFO;-94;RI
M9+.)66,P12$9O+AQ;\$[6C*R-[?^T5^T+JW[+O\ P:TV'C'0;FYL=9M_@_H6
MG6=U;X\VUDO;>TLA(I/0K]HW9ZC&1R*\E_X,SOV6O#WP\_X)^^)OBK'!%-XL
M^(OB*:PN+LJ=\%C8X2&W7)P!YKSR,5 W;T#9V+@ YF\3_@M!X%LV\4F7X7>)
MMBB9_#<:Z47(X8Q@ 1\C;M^6;/S'!/4?J'XC^,?Q1^%/_!/Y_'FK>!;7QC\7
M]"\%1ZUJGA'0I);>+4=5CM%EN;*T.)Y/]:)$C $CMA0 2PKVJN5^-WQO\)_L
MW?"?7?'/CK7K#PSX3\-6K7NI:E>,1%;QK[ %F8G"JB@L[,JJ"Q (!^04/C;_
M (+)_M,Z+%XCL-"^%?PAM+E$G@T62&SAN"I4D;DN&NI4)R,I(ZL#@$ @@:/_
M  2^_P"#@3XS:)^WA#^RM^V5X,L/"WQ#U"Z^PZ7KMK;K:EKR3,EO!<11EH)(
MYE8)%<0$+GRP0V]I%T9_^#G[Q]^UAXVU+2/V2?V5?'_Q>T_2;@P3ZYJ1:TM>
MP#%(E=8P2P($LJMM()5#D#\SO^"IGQK_ &@?BG_P6$_9_P#%/Q^^%&C_  ;\
M?VT^A0V-IIEXEVM[:Q:N[1W!(FF7(D:5<$]%Z8H _HS_ ."M/_**_P#:5_[)
M9XF_]--S7YF_\&1?_)G_ ,:/^QQMO_2)*_3+_@K3_P HK_VE?^R6>)O_ $TW
M-?F;_P &1?\ R9_\:/\ L<;;_P!(DH ]4_X+ ?\ !=7XK_"?]M/3/V4_V4_
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M,OAY?>)M0\/MJMQK'FZ[=Q7-T)I@@9=T442[ (UP-N>N2:=_P48_X)W^!_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
F%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>logo9.jpg
<TEXT>
begin 644 logo9.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0 B17AI9@  34T *@    @  0$2  ,
M   !  $       #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R
M4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M            ]M8  0    #3+4A0("
M                                 !%C<')T   !4    #-D97-C   !
MA    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV
M=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#
M "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $
M/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA
M<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M         !)S4D="($E%0S8Q.38V+3(N,0
M                                        6%E:(        /-1  $
M   !%LQ865H@                     %A96B        !OH@  ./4   .0
M6%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M        %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:
M                      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@
M-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                        9&5S8P         L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                         '9I97<      !.D_@ 47RX $,\4  /MS  $
M$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                     H\    "<VEG(     !#4E0@8W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
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MD:UX/\8:+?>'?%'AVY:SU'3KQ-LUK*,'!QD,I4AE=25=65E)4@GZ^_X(<?\
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M^IR7^MZ5#J<DFEW5C;027$Z26SEHOWBQ^4'"A@90593@@'RG]01K\^_VP/\
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M"]3%('Q^56,U_.EH.L7&@:A'>:7>W%A=0MNCGLYFADC/J&4@@_0U]A?L;_\
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M'6>EV%@D;>#8X8;+4=&54&Z*:R;#_*<@R@-&Y!*NX^8^@^"?V!_@S\,_C_\
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MT6SU+QGXJMEU&.:\@68Z7;2#=#'"&R$9HRKLP 8ERI.% K\D[S_CTDQ_=/\
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M>A^&=.M]*TZW4Y$%O!&L42?@BJ/PH ^./^#DB1HO^")/QZ9696&F6&"#@_\
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M;3&">.XB_>PLDBXDB0\,,XP>"15CX;_LN^!?A9^S;IOPATWP_9W'PZTO1/\
MA'8]%U+.H6\VG^68C;S"<N9D9"582%MP)!S0!^<O_!%K]FO]BO\ 9V_X)+>
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MPFTW2[_;;*SRRG"0J)H+F%R<E%FMG<I&[-7Z1>(/^"4W[!'A/P(WBG5/A/\
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M_B.YL[A;FTL_$.M76I:?;L"2%-L[^7.G(!2X$JD 9!.2?T$BB6")45555&
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M]QD??M".5Z?]F/\ :7\&?MA_ ?PW\2OA[K":]X/\66QN=.O%B>(N%=HY$9'
M9'21'1E(R&0CM7D6H?\ !'W]GN]_85NOV;T\!K;_  DN)3=1Z6NIW<D]G=&7
MSQ<Q7,DK3I*)?FSOP064@HS(?7?V8_V9_!?['?P)\._#7X=Z+'X?\'>%;=K?
?3K%)'E\L-(TLCL[DL[O([NS,22SD]Z .\HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
